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Interaction of Bacteriophage Mu Middle Transcription Activator Protein Mor with
Promoter DNA
Abstract
Gene expression during lytic development of bacteriophage Mu is regulated by a
transcriptional cascade in three phases: early, middle and late. Transcription from the middle promoter
Pm requires the 129-amino acid transcriptional activator Mor, a product of early transcription, and the
Escherichia coli RNA polymerase. The Pm promoter has a recognizable -10 hexamer but lacks a -35
hexamer. Mor binds as a dimer to an imperfect dyad-symmetrical element containing two 6-bp inverted
repeats and centered at -43.5 in Pm. The goals of this study were:
1. To test the prediction from the crystal structure of Mor that residues Y70 and Q68
of the β-strand whose side chains extend away from the protein, make base
specific interactions in the DNA minor groove.
2. To identify the bases between -30 and -57 of the promoter Pm that are important
for its function, in terms of binding to His-Mor and transactivation with
interactions with RNAP subunits, thus optimizing the Mor-binding sequence of
Pm for crystal structure determination for a Mor-DNA duplex.
3. To identify the critical number of bases of Pm required for the best binding of Mor
and to test the stability of Mor binding to DNA probe containing Pm.
To test the prediction of base specific interactions of the side chains of Y70 and
Q68, mutagenesis of the 4-bp spacer region in the minor groove of the Mor-binding site using degenerate
oligonucleotides were done to introduce all possible substitutions. Plate phenotyping on MacConkey agar
plates was used to select Pm-lacZ clones that gave a defective phenotype indicated by white color. All the
white ones had other mutations elsewhere in the plasmid and all the identified substitutions gave
functional phenotypes as indicated by red color of colonies. This experiment revealed that the specific
bases in the minor groove are not extremely important for interaction with the side chains of Y70 and Q68
as they can tolerate mutations. But, gel shift and β-galactosidase expression data with a subset of these
mutations indicated that the bases of the minor groove spacer region do play a modest role in His-Mor
binding and activation of Pm as visible from their variations in the binding and tranactivation assay.
Specific mutations were introduced in the Pm sequence from positions -30 through
-57 upstream of the transcription start site to identify the critical bases for Mor-Pm
interactions. Since Mor binds as a dimer to Pm, the mutations would indicate whether symmetry of the
positions with respect to -43.5 or the specificity of the bases is what determines the importance of the
bases at the respective positions. It would also help identify mutations that could increase Mor binding
and positions that could contribute to interaction with RNAP subunits. Plate phenotyping, in vitro binding
assay and in vivo β- galactosidase assays were done for all the mutations. The 6-bp imperfect
dyadsymmetrical sequences flanking the minor groove spacer were found to be the most critical for Mor
binding. Within the dyad-symmetry element, bases at positions -38 to -40 and -47 to -49 are the most

important as they do not tolerate any base changes. The region flanking the Mor-binding sites on either
side does not seem to be critical for Mor binding, but the results indicate their function in transactivation,
probably by influencing interactions of Mor with the RNAP subunits or conformational changes in the
interactions at Mor-DNA-RNAP interfaces.
Two mutations, -46C alone and in combination with -50T, were specifically
interesting as they bound to wild-type His-Mor more effectively than wild-type promoter, but displayed
reduced in vivo activity. This observation led to the prediction that Mor also functions in promoter
clearance and that higher binding of Mor to the promoter somehow negatively affects release of the core
RNAP for transcription. This could mean that Mor has dual functions at the middle promoter: recruitment
of RNAP and release of core RNAP during transcription initiation. Oligonucleotides with these specific
mutations can be used for crystal structure determination for a Mor-DNA duplex as they stabilize the
complex.
Different length oligonucleotides were used in gel shift assays with wild-type HisMor to identify the critical number of bases needed for efficient Mor binding. This
experiment revealed that at least 20-bp, centered at -43.5, is needed for detectable binding to His-Mor.
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Abstract
Gene expression during lytic development of bacteriophage Mu is regulated by a
transcriptional cascade in three phases: early, middle and late. Transcription from the
middle promoter Pm requires the 129-amino acid transcriptional activator Mor, a product
of early transcription, and the Escherichia coli RNA polymerase. The Pm promoter has a
recognizable -10 hexamer but lacks a -35 hexamer. Mor binds as a dimer to an imperfect
dyad-symmetrical element containing two 6-bp inverted repeats and centered at -43.5 in
Pm. The goals of this study were:
1. To test the prediction from the crystal structure of Mor that residues Y70 and Q68
of the β-strand whose side chains extend away from the protein, make base
specific interactions in the DNA minor groove.
2. To identify the bases between -30 and -57 of the promoter Pm that are important
for its function, in terms of binding to His-Mor and transactivation with
interactions with RNAP subunits, thus optimizing the Mor-binding sequence of
Pm for crystal structure determination for a Mor-DNA duplex.
3. To identify the critical number of bases of Pm required for the best binding of Mor
and to test the stability of Mor binding to DNA probe containing Pm.
To test the prediction of base specific interactions of the side chains of Y70 and
Q68, mutagenesis of the 4-bp spacer region in the minor groove of the Mor-binding site
using degenerate oligonucleotides were done to introduce all possible substitutions. Plate
phenotyping on MacConkey agar plates was used to select Pm-lacZ clones that gave a
defective phenotype indicated by white color. All the white ones had other mutations
elsewhere in the plasmid and all the identified substitutions gave functional phenotypes
as indicated by red color of colonies. This experiment revealed that the specific bases in
the minor groove are not extremely important for interaction with the side chains of Y70
and Q68 as they can tolerate mutations. But, gel shift and β-galactosidase expression data
with a subset of these mutations indicated that the bases of the minor groove spacer
region do play a modest role in His-Mor binding and activation of Pm as visible from
their variations in the binding and tranactivation assay.
Specific mutations were introduced in the Pm sequence from positions -30 through
-57 upstream of the transcription start site to identify the critical bases for Mor-Pm
interactions. Since Mor binds as a dimer to Pm, the mutations would indicate whether
symmetry of the positions with respect to -43.5 or the specificity of the bases is what
determines the importance of the bases at the respective positions. It would also help
identify mutations that could increase Mor binding and positions that could contribute to
interaction with RNAP subunits. Plate phenotyping, in vitro binding assay and in vivo βgalactosidase assays were done for all the mutations. The 6-bp imperfect dyadsymmetrical sequences flanking the minor groove spacer were found to be the most
critical for Mor binding. Within the dyad-symmetry element, bases at positions -38 to -40
and -47 to -49 are the most important as they do not tolerate any base changes. The
region flanking the Mor-binding sites on either side does not seem to be critical for Mor
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binding, but the results indicate their function in transactivation, probably by influencing
interactions of Mor with the RNAP subunits or conformational changes in the
interactions at Mor-DNA-RNAP interfaces.
Two mutations, -46C alone and in combination with -50T, were specifically
interesting as they bound to wild-type His-Mor more effectively than wild-type promoter,
but displayed reduced in vivo activity. This observation led to the prediction that Mor
also functions in promoter clearance and that higher binding of Mor to the promoter
somehow negatively affects release of the core RNAP for transcription. This could mean
that Mor has dual functions at the middle promoter: recruitment of RNAP and release of
core RNAP during transcription initiation. Oligonucleotides with these specific mutations
can be used for crystal structure determination for a Mor-DNA duplex as they stabilize
the complex.
Different length oligonucleotides were used in gel shift assays with wild-type HisMor to identify the critical number of bases needed for efficient Mor binding. This
experiment revealed that at least 20-bp, centered at -43.5, is needed for detectable binding
to His-Mor.
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Chapter 1: Introduction
The central dogma of molecular biology is: DNA is transcribed to RNA which is
translated to protein. Transcription is the process by which messenger RNA is made from
the DNA using the anti-sense strand as the template. The sense strand of DNA has the
codons for amino acid sequence of the protein that it codes for. In the subsequent step,
mRNA is translated into amino acid sequence of the protein. Thus, transcription is the
first important process by which the genetic information stored in the DNA is expressed
(Figure 1).
Transcription machinery
DNA-dependent RNA polymerase is the key enzyme responsible for transcription
in living cells. It catalyzes the formation of 5' - 3' phosphodiester bonds between
ribonucleoside triphosphates.
RNA polymerase can be divided into 2 evolutionary conserved groups based on
the number of subunits constituting the enzyme; single-subunit RNA polymerases and
multi-subunit RNA polymerases. Single subunit RNA polymerases are the simplest form
of the enzyme in mitochondria and phages SP6 and T7 (McAllister and Raskin, 1993;
Tunitskaya and Kochetkov, 2002). Prokaryotic and eukaryotic RNA polymerases are
multi-subunit enzymes. Prokaryotic cells are characterized by one RNA polymerase,
while eukaryotic cells have 3 different RNA polymerases: Pol I for rRNA synthesis, Pol
II for mRNA synthesis and Pol III for tRNA synthesis (Cramer, 2002).
Structural studies between the core subunits of eubacterial, archeal and eukaryotic
RNA polymerases revealed that the homology of their amino acid sequences is extended
to the structure and function of these proteins. They also show similarities in the relative
position of the subunits, relative positions of the functional determinants, structural
folding topologies of the subunits and in their mechanisms of interaction with DNA
(Cramer, 2002). The most highly conserved regions are around the active center of the
enzyme. This similarity decreases towards the outer part; this region is the target for
transcriptional regulators (Ebright, 2000). The involvement of multiple subunits of Pol II
and the larger size of pre-initiation complexes in eukaryotes pose a formidable challenge
to dissect the key processes of eukaryotic transcription. Instead, the simple and highly
similar bacterial RNA polymerase serves as an excellent model system in understanding
the transcriptional machinery in general.
The prokaryotic core RNAP consists of 5 subunits: α (2 copies), β, β' and ω
(Figure 2). In association with the σ factor in a multistep and cooperative process, the
core RNAP forms the holoenzyme (Borukhov and Nudler, 2003). The assembly pathway
of the holoenzyme is represented as follows:
α → α2 → α2β → α2ββ′ → α2ββ′ω (CORE) → α2ββ′ωσ (HOLOENZYME)
(Ishihama, 1981; Ishihama, 1993).
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Figure 1: The central dogma of biology.
Transcription of DNA to RNA to protein.
This dogma forms the backbone of molecular biology and is represented by three stages:
1. Replication of DNA: The DNA replicates its information in a process that
involves many enzymes.
2. Transcription of the information from DNA to RNA: The DNA codes for the
production of messenger RNA (mRNA) during transcription. In eucaryotic cells,
the mRNA is processed (essentially by splicing) and migrates from the nucleus to
the cytoplasm.
3. Translation of the information from messenger RNA to protein sequence:
Messenger RNA carries coded information to ribosomes. The ribosomes "read"
this information and use it for protein synthesis. This process is called translation.
Reprinted with permission from Access Excellence @ the National Health Museum
http://www.accessexcellence.org/RC/VL/GG/central.php, Accessed June 18, 2008.
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Interaction interface between σ, β and
β’ subunits of the RNAP
Interaction interface between α and β
subunits of the RNAP

β

α

Interaction interface between σ and α
subunits of the RNAP

σ70
α

β’

Interaction interface between α and β’
subunits of the RNAP
Figure 2: Representation of the holoenzyme of bacterial RNAP.
The holoenzyme, with its subunits σ70, α (2 copies), β and β' are shown in the figure.
The smallest subunit ω is not shown in the figure. The interaction interfaces between the
various subunits are shown by arrows.
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σ subunit
The σ factor, conferring promoter specificity, is directly responsible for promoter
recognition and initiation of transcription. It is involved in the crucial process of
conversion of the core enzyme into the holoenzyme during transcription initiation. It also
functions in promoter melting, stabilization of the resulting single stranded DNA, binding
of initiating nucleotide triphosphates and as a target for multiple transcriptional regulators
(Li et al, 1994; Gross et al, 1998; Lonetto et al, 1998; Nickels et al, 2002; Dove et al,
2003; Mitchell et al, 2007). In E.coli, there are different σ factors which recognize
different promoters.Promoters of most of the genes involved in house-keeping function
are recognized by σ70. Promoters of the genes involved in nitrogen metabolism are
recognized by σ54, also called σN. Recognition of the promoters of the heat shock
response genes is by σ32. Promoters of the genes for motility and chemotaxis are turned
on by σ28. Promoter recognition of the stationary phase and stress response genes is
controlled by σ38 (Ishihama, 2000; Grouse et al, 2006). Based on amino acid sequence
comparisons of members of the σ70 family, it has 4 highly conserved regions, regions
1.0-4.0 (Lonetto et al, 1992) which are the functional domains of σ subunit. These are
further divided into sub-regions to which specific functions are assigned based on
biochemical and genetic studies. These highly conserved regions of the σ subunit have
specific functions that contribute to the subunit’s structure and function (Figure 3).
Region 1.0: The self-inhibitory domain 1.1 of σ, is responsible for masking the DNAbinding regions of σ before it binds the core complex to form the holoenzyme
(Dombroski et al, 1993). It was later shown that this region may bind the main channel of
the core enzyme by widening the channel and enhancing the binding of DNA duplex
(Bowers and Dombroski, 1999; Borukhov and Severinov, 2002). Region 1.2 along with
2.1 and 2.2 is believed to create the hydrophobic interface for interaction with core
enzyme. Recently, along with region 2.4, region 1.2 was also shown to be involved in
promoter recognition of the -10 element (Zenkin et al, 2007).
Region 2.0: Region 2.1 and 2.2 help form the holoenzyme by specifically interacting with
the β' subunit (Sharp et al, 1999). Region 2.3-2.4 bind single stranded DNA in the
formation of the open complex by promoter melting (Juang and Helmann, 1994) and
interacts specifically with the -10 element of the promoter (Malhotra et al, 1996;
Sevostyanova et al, 2007).
Region 3.0: The subregions, 3.0-3.2 are implicated in promoter recognition, proper
positioning of DNA-binding domains of σ, binding of nucleotides, abortive initiation and
promoter clearance. Region 3.0 is involved in the recognition of the extended -10
promoter element (TGn -10), which compensates for the absence of a -35 element in
these promoters (Malhotra et al, 1996; Barne et al, 1997). Regions 3.1 and 3.2 form a
loop called the σ3.2 loop as it is predominantly formed by region 3.2. The presence of
this loop causes steric hindrance to the growing nascent transcript and is thought to be
responsible for abortive initiation. The transcript needs to displace this loop in order to
initiate elongation (Borukhov and Nudler, 2003; Murakami and Darst, 2003).
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Interaction
with the
core RNAP

Selfinhibitory
domain

3.2 loop:
Abortive
initiation

Promoter
melting
Core binding and
recognition of -10

Extended -10
recognition

Recognition
of -35

-10 recognition
Core
binding

Figure 3: Representation of the different regions of the σ subunit of the RNAP with their
functions.
Modified with permission from Elsevier Limited. Murakami KS, Darst SA. Bacterial
RNA polymerases: the wholo story. Curr Opin Struc Biol. 2003, 13(1): 31-9.
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Region 4.0: Region 4.0 which is also called the σ-CTD plays a significant role in
recognition of the -35 hexamer, interaction with the core enzyme, repositioning of
DNA-binding domains of σ and activation of Class II activator dependent promoters
(Campbell et al, 2002; Dove et al, 2003; Geszvain et al, 2004). Region 4.2 recognizes the
-35 element of the promoters (Campbell et al, 2002). Conformational changes induced by
σ 4.1 - β flap interactions reorient σ4.2 and σ2.4 such that σ4.2 is in a position to interact
with -35 element of the promoters (Callaci et al, 1999; Kuznedelov et al, 2002).
β and β' subunits
The β and β' subunits form the catalytic center of the RNAP, forming the roof and
the floor of the DNA tunnel respectively. Various regions of these subunits are
specifically involved in interaction with α subunit, promoter melting, separation of the
DNA:nascent RNA hybrid during elongation, closure of the main channel during
elongation and formation of the secondary channel for entry of incoming nucleotides
(Zhang et al, 1999; Vassylyev et al, 2002).
α subunit
The α subunit is a 329-amino acid protein which is folded into two domains that
are connected by a 13-amino acid flexible linker. The two domains are the N-terminal
domain (α-NTD; amino acid residues 1-235) and the C-terminal domain (α-CTD; amino
acids 249-329). The dimerization of the 2 α-NTDs generates a platform for the assembly
of the core complex. The N-terminal domain of the α subunit helps in the assembly of the
β and β' subunits. It also plays a minor role as a target for catabolite activator protein
(CAP) in some CAP-dependent Class II promoters (Ebright and Busby, 1995). The
C-terminal domain of the α subunit can contact the upstream promoter region
(UP-element) and can also interact with activator proteins (Ross et al, 1993; Busby and
Ebright, 1994; 1995). The flexible linker can be 13 to 36 amino acids long and is thought
to provide the flexibility for α-CTD to reach the UP-elements. The natural length of the
linker is the most optimal for α-CTD-DNA interactions (Meng et al, 2001).
ω subunit
This is the smallest subunit of RNAP and consists of 90 amino acids. This subunit
was in the past thought to be an impurity which tightly binds to RNAP. Deletion of the
rpoZ gene encoding the ω subunit does not affect cell growth or activity of RNAP
(Vassylyev et al, 2002). It is now clear that the ω subunit predominantly acts as a
chaperone in folding of the β' subunit and its subsequent assembly into the α2ββ’
complex. It also participates in physical protection of the β' subunit, RNAP assembly and
σ factor recruitment. It is also thought to play roles in mediation of the stringent response,
transcriptional regulation, stress adaptation of RNAP and survival in stationary phase
(Mathew and Chatterji, 2006).
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Promoter architecture
Promoters are the minimal DNA sequence elements located upstream of a
transcription start site and provide a control point for regulated gene transcription. The
promoter acts as a specific recognition site for RNAP and transcription factor proteins.
Analysis of many E.coli promoters has revealed that there are 3 conserved promoter
elements, characteristic of a typical eubacterial σ70 promoter (Hawley and McClure,
1983) as represented in Figure 4:
1. The -10 sequence: Also called Pribnow Box, it is centered approximately 10 base
pairs upstream of the transcription start site, with a consensus sequence 5′
TATAAT 3′.
2. The -35 sequence: Centered approximately 35 base pairs upstream of the
transcription start site, with a consensus sequence 5′ TTGACA 3′.
3. The spacer: It is typically located 17±1 base pairs between the two important
promoter elements, -10 and -35 (Harley and Reynolds, 1987; deHaseth et al,
1998).
Thus, the consensus promoter architecture can be represented as follows:
5’ TTGACA ---- 17±1 ---- TATAAT 3’.
The strength of a promoter can be correlated to the degree of similarity of these promoter
sequence elements to the consensus; the higher the similarity, stronger the promoter.
Promoter recognition by the RNAP holoenzyme (Figure 5) is primarily achieved
through interactions of σ2.4 with -10 hexamer and σ4.2 with -35 hexamer, though recent
research has indicated the involvement of other regions of RNAP either directly or
indirectly making these inteactions more complex. It has been shown that σ 1.2 can also
play a significant role in the recognition of the -10 hexamer (Malhotra et al, 1996;
Campbell et al, 2002; Murakami et al, 2002; Vassylyev et al, 2002; Zenkin et al, 2007).
An additional class of promoters, called extended -10 promoters, is characterized
by the presence of a TGn trinucleotide sequence immediately upstream of the -10
hexamer and the absence of a recognizable -35 element (Keilty and Rosenberg, 1987).
Recent research raises the possibility that a few more bases may play a role in these
extended -10 promoters (Shultzaberger et al, 2007; Hook-Barnard et al, 2006). In the
absence of a recognizable -35 element, the promoter activity is independent of
interactions of σ4.2 with the -35 hexamer (Kumar et al, 1993), but is dependent on
contacts between σ3.0 and the extended -10 sequence (Barne et al, 1997).
A strong correlation between the strength of rrna P1 promoters and a 20-bp long
AT-rich region located upstream of the -35 hexamer identified a new promoter element
called the Upstream Promoter element (UP-element). This was defined as the promoter
recognition element for the α-CTD of RNAP (Ross et al, 1993; Ross, 1993; Ross et al,
1994; Ebright and Busby, 1995; Husnain and Thomas, 2008). The additional interaction
of the α-CTD with the UP-element results in efficient recruitment of RNA polymerase to
the promoter and contributes to the strength of the UP-element containing promoters
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TTGACA
concensus

-60
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TATAAT
concensus
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Figure 4: Eubacterial σ70 promoter architecture and promoter elements.
The DNA sequences from -60 to the +1 transcription start site are shown as a thick black
line. The red bent arrow represents the +1 transcription start site and the rectangle boxes
denote the specific elements of a bacterial promoter. Individual promoter elements are as
written below their respective positions and the TGn motif represents the extended -10
element. The consensus sequences for the -10 and -35 are given above their respective
positions.
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Figure 5: RNA polymerase and its interactions at promoters.
a) A model based on crystallographic studies of the initial docking of the RNA
polymerase holoenzyme to a promoter. The DNA strands are shown in green, with the
-10 and -35 elements highlighted in yellow and the TGn extended -10 and the UP
elements highlighted in red. RNA polymerase is shown with the β and β′ subunits
coloured light blue and pink, respectively, α-NTDs are coloured grey and the different
domains of σ are coloured red. Grey spheres labelled I and II, represent the domains of
α-CTD that bind to the promoter. The RNA polymerase active site is denoted by the
Mg2+ ion, (magenta).
b) A cartoon representation of the model of RNAP interaction at a bacterial promoter,
illustrating the different interactions between promoter elements and the RNA
polymerase. The consensus sequences for the -35 (TTGACA), extended -10 (TGn) and
-10 (TATAAT) elements are shown.
Reprinted with permission from Nature Publishing Group. Browning DF, Busby SJ. The
regulation of bacterial transcription initiation. Nat Rev Microbiol. 2004, 2(1): 57-65.
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(Aiyar et al, 1998; Gourse et al, 2000). This element has two subsites, proximal and
distal, which function as binding sites for the two α-CTD’s (Estrem et al, 1999).
Holoenzyme assembly
Dimerization of α subunit is the first step in the assembly pathway, which
provides a platform for the other subunits of the RNAP (β, β′, ω and σ) to assemble.
Thus, α plays a critical role in the assembly of the core enzyme (reviewed by Ishihama,
1981; Ishihama et al, 1987).
The assembly pathway of the holoenzyme is represented as follows:
α → α2 → α2β → α2ββ′ → α2ββ′ω (CORE) → α2ββ′ωσ (HOLOENZYME).
Association of σ subunit to the core enzyme forms the holoenzyme complex. The
type of σ factor associated with the core enzyme directs it to activate transcription from a
specific promoter. Under normal growth conditions, σ70 associates with the core enzyme
to direct transcription from the housekeeping genes. The type of σ factor to associate with
the core enzyme depends on the cellular needs at that time. Alternative σ factors come to
play during stressful or nutrient-depriving conditions. Occlusion of the core-binding
determinants of σ by anti-sigma factors depending on environmental needs dictates the
availability of the appropriate σ type for interactions with core RNAP (Mathee and
Hughes, 1998; Campbell et al, 2003). The interactions between most of the σ factors and
the core enzyme are similar and comparable. Interactions between σ1.2 and σ2.2 with the
coiled coil element of β′ and of σ4.0 with the β-flap domain form the primary and
secondary contacts respectively between σ and the core RNA polymerase (Borukhov and
Severinov, 2002; Vassylyev et al, 2002; Murakami et al, 2002).
Formation of closed promoter complex
Binding of the core enzyme to the σ induces considerable conformational changes
in the σ subunit that have important functional aspects. These conformational changes
place the σ4.0 and σ2.0 in optimal places in the complex conferring on them the
necessary specificity in terms of interactions with -35 and -10 elements of the promoter
respectively (Callaci, 1999; Kuznedelov et al, 2002; Geszvain et al, 2004). These
conformational changes in the RNAP holoenzyme also have functional implications in
promoters with the extended -10 or the UP-element. Specific interactions between the
σ2.4 and β facilitates opening of the main channel allowing entry of duplex DNA into it
as shown in Figure 6 (Polyakov et al, 1995; Murakami and Darst, 2003). Transcriptional
activators play a major important role in the recruitment of RNAP to the promoter
through specific interactions with the RNAP subunits, primarily the more accessible
α-CTD (Ebright and Busby, 1995).
The role of DNA bending at this step of association of RNAP with the DNA in
presence of activator is stoichiometrically important. DNA bending in some cases is a
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consequence of the activator-DNA interactions while in others DNA bending facilitates
protein-DNA interactions. This distortion of DNA is important for the complex proteinprotein and protein-DNA interactions at the promoter. The activators involved in DNA
bending are called architectural activators as they influence the promoter architecture.
Regulators of transcription through DNA bending sustain or inhibit the active promoter
configuration to the effect that they can either activate or repress transcription depending
on their effect (Perez-Martin and Espinosa, 1993; Perez-Martin and de Lorenzo, 1997).
The regions 2.4 and 4.2 of σ subunit recognize the -10 and -35 promoter elements
respectively relative to the transcription start site (+1). This forms the closed promoter
complex which is in equilibrium with free RNAP and promoter DNA. The formation of
this closed promoter complex is the first step in transcription initiation. It also involves
other interactions (like the one between α-CTD and UP element) and active
conformational changes at the promoter making it optimum for transcription.
The transcription process
There are three stages in the transcription process: initiation, elongation and
termination. Biochemically distinct steps characterize the basic transcription cycle of
E.coli RNAP. Transcription initiation can be further sub-divided into three stages: open
promoter complex formation, abortive initiation and promoter escape (Borukhov and
Severinov 2002). Promoter complex formation itself is a multi-step process involving
binding of RNAP to the promoter forming the closed complex (RPc), transition from
closed complex to transcriptionally competent open complex (RPo) with additional
intermediate stages involving active conformational changes in the complex. The open
complex is transcriptionally and enzymatically active. After a few abortive transcripts,
promoter clearance allows the transition into transcription elongation during which RNA
is made by adding nucleotide tri phosphates to the growing chain till the RNAP
encounters the transcription stop site at which the transcription process is terminated.
Thus, the process of RNA synthesis by RNAP requires that this protein has multiple
functions either by itself or in concert with other proteins; it acts as a sequence-specific
DNA-binding protein, then as a DNA strand-separation protein and finally as RNA
synthetase.
Promoter melting and formation of open complex
The exposure of the template strand for transcription requires strand separation of
the duplex DNA. The DNA duplex in the -10 region is typically melted from -11 to +3
and includes the transcription start site +1 (Young et al, 2002). Region 2.3 of σ subunit
stabilizes the initial transcription bubble extending downstream past the transcription start
site to form the open promoter complex (Malhotra et al, 1996). In this position, and
associated with significant conformational changes, the single stranded template strand is
enclosed in an active site tunnel formed by the main channel (Figure 6). The downstream
double stranded DNA from +5 to +12 from the transcription start site is enclosed by the β
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Figure 6: Structural transitions during the steps of transcription initiation.
Shown are cross-sectional views of the RNAP holoenzyme (β-flap, blue; σ, orange; rest
of RNAP, gray; catalytic Mg2+, yellow sphere), promoter DNA (template strand, dark
green; nontemplate strand, light green; −10 and −35 elements, yellow) and the RNA
transcript (red) at the RPc (a), intermediate (I) (b), RPo and abortive initiation (c), end of
abortive initiation (d), promoter clearance (e) and TEC (f) stages of transcription
initiation. The view is looking down on top of the β subunit, but with most of β removed,
revealing the inside of the RNAP active site channel.
Reprinted with permission from Elsevier Limited. Murakami KS, Darst SA. Bacterial
RNA polymerases: the wholo story. Curr Opin Struc Biol. 2003, 13(1): 31-9.
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and β' subunits, stabilizing the complex. In the presence of nucleotides that enter the
complex through a secondary channel and in association with σ3.0, transcription is
initiated from the +1 transcription start site in the RNAP active site (Severinov et al,
1994; Murakami et al, 2002).
Abortive initiation
The process of abortive initiation involves synthesis of a few short aborted
transcripts, about 2-12 nucleotides long and their release from the complex in an
unsuccessful attempt to continue transcription. The σ3.2 loop plays a major role in this
process of abortive initiation. Two structural elements of σ3.2, a short helix and a long
linker were identified to be the root cause for abortive initiation. The elongating RNA
chain of 2-3 nucleotides encounters the short helix and this might cause the dissociation
of transcript from the complex. Similarly, the σ3.2 loop is encountered by longer
transcripts of 2-8 nucleotides on their way out of the complex (Vassylyev et al, 2002). At
this juncture, if the RNA chain fails to displace the σ3.2 loop out of its way, this nascent
transcript is cut by the RNAP and it dissociates from the complex. When the RNA chain
elongates to about 12 nucleotides long, it is sufficient to fill the RNA-DNA hybrid and
the upstream RNA channel completely under the β-flap, and it is now capable of
displacing the σ3.2 loop. This ends the process of abortive transcription (Murakami and
Darst, 2003).
Promoter clearance
This biochemical step drives the complex to initial stages of transcription
elongation. During promoter escape, interactions between σ4.2 and the -35 element are
destabilized. The RNAP can now leave the promoter and translocate downstream as RNA
chain is elongated. The initial stage of transition into elongation does not require the
complete dissociation of σ subunit, though eventually the σ factor is completely released
from the complex, forming the ternary elongation complex with the core RNAP
(Murakami and Darst, 2003). The formation of this elongation complex requires
significant conformational changes in the complex. This ternary elongation complex has
high processing ability to elongate the transcript.
Transcription elongation
During promoter clearance, the core enzyme leaves the promoter and enters the
highly productive elongation phase of transcription. As the productive initial transcribing
complex enters the elongation phase, σ70 is released from the promoter while the core
enzyme continues transcription (Carpousis and Gralla, 1985; Krummel and Chamberlin,
1989). This is diagrammatically represented in Figure 7. Translocation is proposed to
involve scrunching of downstream DNA into the enzyme interior, generating strain that
ultimately leads to the displacement of σ contacts on promoter DNA (Vo et al, 2003).
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Figure 7: Structure-function model of the transcription elongation complex.
(a) Structure of the nucleic acid scaffold of TEC. Five parts are distinguished: the
upstream DNA duplex; the downstream DNA duplex; the 8-9 bp RNA-DNA hybrid; the
single-stranded region of DNA in the transcription bubble; and the emergent ssRNA
upstream of the hybrid. Filled circles represent DNA (template strand in red; nontemplate
strand in yellow). The DNA-binding site is represented by a sliding clamp that encloses 9
bp of the downstream DNA duplex. The hybrid binding site that accommodates the
RNA-DNA heteroduplex is represented by two zip-locks that hold onto the edges of the
heteroduplex and either zip or unzip the hybrid, maintaining its constant size during
lateral movement of RNAP. The gray area represents the RNAP footprint.
(b) Schematic model of TEC showing its main features. White lines show the
correspondence between the functional and structural features of TEC.
Reprinted with permission from Elsevier Limited. Korzheva N, Mustaev A. Transcription
elongation complex: structure and function. Curr Opin Microbiol. 2001, 4(2): 119-25.
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This results in the formation of a stable elongation complex in which the transcript is
tightly bound in the RNA exit channel. The minimal elongation complex, a ternary
complex, consists of the core RNAP bound to the DNA and nascent RNA, with many
cooperative contacts increasing the complex stability (Borukhov et al, 2005). The process
of RNA-DNA hybrid formation and subsequent RNA displacement from the template,
and the mechanism of DNA translocation is a highly complex process involving
tremendous structural and stoichiometric changes in the individual components of the
machinery (Vassylyev et al, 2007). This process of transcription elongation is extremely
complex as the RNAP goes through various conformational states for function and
regulation (reviewed by Nudler, 1999; Erie, 2002). The earliest model proposed for
elongation of transcript is called the inchworm model, according to which two distinct
RNA and DNA-binding sites exist at the leadin and lagging edge of the active site of the
polymerase (Uptain et al, 1997). The catalytic site for phosphodiester bond formation is
at the lagging edge of the RNA binding site. RNA chain elongation proceeds in two
phases; nucleotide addition and translocation. As nucleotide addition to the 3’-OH
terminus continues, the leading edge is filled with the RNA transcript, conformational
changes in the complex releases the template and transcript leading to translocation of the
elongation complex (Krummel and Chamberlin, 1992; Uptain et al, 1997). The
complexity of this process is enhanced by the fact that this could involve alternating
phases of discontinuous (or inchworm-like) as well as monotonic movements of the
polymerase.
Transcription termination
Transcription in E.coli is terminated by two distinct mechanisms: Rho-dependent
and Rho-independent. Rho-independent terminators are intrinsic terminators of inverted
repeats coded in the DNA sequence followed by a stretch of A’s. The IR forms a hairpin
in the RNA which pulls the stem bases away from the DNA template, leaving only the
weak U-A pairs to maintain the DNA-RNA hybrid, thus releasing the RNA and making it
fall off the DNA due to conformational changes in the RNAP. In Rho-dependent
termination, the hexameric protein Rho binds to the nascent RNA of the transcription
complex and releases it at defined Rho-dependent terminators along the template. Thus,
at termination the RNA transcript is released from the elongation complex and
conformational changes in the RNAP core release it from the DNA (Richardson, 1993;
Ciampi et al, 2006; Banerjee et al, 2006).
Transcription regulation
Potentially, regulation of transcription can occur at any stage in the process,
starting at initiation and continuing upto termination of transcription. Regulatory factors
can function in enhancing or disrupting the various stages during transcription. Research
in this field have identified and characterized the following regulatory elements in the
process of transcription.
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Regulation by σ factors
The type of σ factor associated with the core enzyme directs it to activate
transcription from a specific promoter. Under normal growth conditions, σ70 associates
with the core enzyme to direct transcription from the housekeeping genes. The type of σ
factor to associate with the core enzyme depends on the cellular needs at that time.
Alternative σ factors come into play during stressful or nutrient-depriving conditions.
Occlusion of the core-binding determinants of σ by anti-sigma factors depending on
environmental needs dictates the availability of the appropriate σ type for interactions
with core RNAP (Mathee and Hughes, 1998; Campbell et al, 2003).
Regulation by small ligands
Small ligands provide an alternative mechanism by which RNA polymerase can
respond quickly and efficiently to the environment. The best example is guanosine 3', 5’
bisphosphate (ppGpp), which is synthesized when amino-acid availability is restricted to
the extent that translation is also limited. The ppGpp ligand works by destabilizing open
complexes at promoters. In fact, although the interaction of ppGpp with RNA polymerase
is not promoter-specific, ppGpp-dependent inhibition occurs at promoters that control
many of the genes that encode the protein products that are needed for translation. Many
of these promoters recruit RNA polymerase very effectively and so, potentially, can
initiate transcription at the maximum possible rate. However, to achieve these rates, the
open complex must be stabilized and this requires higher ATP and lower ppGpp
concentrations (Browning and Busby, 2004).
Regulation by small RNAs
The bacterial 6S RNA was the first sRNA shown to inhibit transcription by
binding directly to the housekeeping holoenzyme form of RNA polymerase (σ70-RNA
polymerase in E. coli) (reviewed by Wassarman, 2007). It resides within the active site of
RNA polymerase and blocks access to promoter DNA. This 6S RNA regulation of
transcription leads to altered cell survival, perhaps by redirecting resource utilization
under nutrient-limiting conditions.
Regulation by activators and repressors
Based on the nature of regulation, positive regulators (those that turn the genes
ON) are called activators and negative regulators (those that turn the genes OFF) are
called repressors. Small molecules that cooperatively interact with activators are called
inducers and those that interact with repressors are called co-repressors. Most of the
positively controlled bacterial promoters lack one or more promoter elements due to
which RNA polymerase is unable to bind to these promoters by itself. Activators that
function at this step are sequence-specific DNA-binding proteins that bind to upstream
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sequences in the promoter. Protein-protein interactions between activator proteins and
RNAP subunits demands conformational changes to stereotypically accommodate the
interactions (reviewed by Browning and Busby, 2004). Activators that act at the
transcription initiation stage target the recruitment of RNAP to the promoter through
interactions with various subunits of RNAP and could also mediate transition from closed
complex to open complex by stabilizing the intermediate steps of isomerization (Dove et
al, 2000). Based on the subunit of RNA polymerase it interacts with and the location of
the binding site on the promoter, many activators are grouped into two classes, Class I
and Class II. Class I activators have their binding site several bases upstream of the -35
element even as far as -60 from the transcription start site and recruit the RNA
polymerase through its interaction with α-CTD of RNAP. In contrast, Class II activators
bind to promoters immediately upstream of or overlapping the -35 element and can affect
multiple steps of initiation by its interaction with the α-CTD, α-NTD and/or C-terminal
domain of the σ subunit of RNA polymerase. Activators can also function by altering the
conformation of the target promoter to enable the interaction of RNAP with -10 and/or
-35 promoter elements (reviewed by Browning and Busby, 2004).
Most of the repressors act by binding to the promoter thereby preventing RNAP
binding by steric hindrance, but they can also affect open complex formation and
promoter clearance. Repressors can also function by looping of the promoter elements
thereby preventing their interaction with RNAP. They can also function by modulation of
functional domains of activator proteins thereby preventing their interaction with RNAP
(reviewed by Browning and Busby, 2004). Initial stages of the RNAP binding to the
promoters is the primary target for most repressors (Rojo, 1999; Rojo, 2001). All the
classical repressors, LacI, PurR, TetR and TrpR are examples of repressors that act by
binding to sequences within the promoter and block RNA polymerase binding to the
promoter by steric hindrance. Repressors can also function by destabilization of open
complexes leading to release of RNAP from the promoter or by stimulation of
isomerisation. Most of the repressors that act at the promoter clearance step generally
increase the affinity of RNA polymerase for the promoter, thereby preventing the release
of the enzyme from the promoter (Rojo et al, 1998). Any stabilization of σ4.0/flap
interaction might also result in stronger σ4.0/-35 contacts that prevent promoter clearance.
Regulation by small molecules
The secondary channel of RNA polymerase that transports NTPs to the active site
is a target for a new class of regulators (Nickels and Hochschild, 2004). Microcin J25, a
21-residue long peptide with antibiotic properties blocks the NTP entry by binding within
the secondary channel (Adelman et al, 2004; Mukhopadhyay et al, 2004). DksA, a
regulator of rRNA transcription also mediates regulation by binding within the secondary
channel (Perederina et al, 2004). Structural studies of the multi-subunit RNAPs from
bacterial and eukaryotic cells have illuminated the presence of large, solvent-accessible
surfaces with numerous functionally crucial cavities and channels, the blocking of which
would likely inhibit transcription. Among transcription factors that bind to bacterial RNA
polymerase (RNAP) and modulate its activity, a number of small molecules irreversibly
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inhibit RNAP thereby causing cell death (reviewed by Artsimovitch and Vassylyev,
2006). Small molecule inhibitors such as rifampicin and sorangicin bind to the β subunit
within the channel and act by directly blocking the path of the growing RNA chain 2-3
nucleotides in length (Campbell et al, 2001; Campbell, 2005). Recent studies of the
RNAP inhibitors indicate that although most of them possess unique mechanisms of
action, they are unable to stop RNAP directly through steric hindrance, but rather utilize
an indirect approach by limiting the access of the Mg2+ ions and substrates to the RNAP
active site. Such indirect modulation of the RNAP catalytic center may in fact represent a
common theme in transcription regulation (Artsimovitch et al, 2005; reviewed by
Artsimovitch and Vassylyev, 2006; reviewed by Chopra, 2007).
Bacteriophage Mu
Bacteriophage Mu is a temperate bacteriophage of E. coli K-12 and also infects
several other bacterial species like Citrobacter freundii, Klebsiella, Pseudomonas,
Rhizobium and Alcaligenes eutrophus (reviewed by Symonds et al, 1987; Pato, 1990). It
is a generalized transducing phage as well as the largest and the most efficient transposon
(Harshey and Jayaram, 2006). Being a temperate phage, Mu has a regulatory circuit that
functions as a switch between the lysogenic and lytic modes during its life cycle. Upon
infection, a complex of phage proteins and the linear double-stranded 37-kb DNA
genome, flanked by heterogenous host sequences, is injected into the host cell (Au et al,
2006). The genome is then converted into a non-covalently closed form through the
action of phage-encoded transposition proteins which binds to the ends of Mu DNA
forming a protein-DNA complex that has been proposed to serve as an intermediate to
integration into the host chromosome (Nakai et al, 2001). Through a random nonreplicative transposition mechanism, the phage genome is then integrated into the
bacterial host chromosome, leading to duplication of the 5-bp target site which flanks the
integrated copy of the Mu genome (Liebart et al, 1982; Chaconas et al, 1983; Sivan et al,
1988).
While a majority of the infected cells enter the lytic cycle, a fraction of the
population becomes stable lysogens. Lysogeny is maintained by the repressor c, by
binding to the early promoter, Pe and is stabilized by three host proteins: IHF (Integration
host factor), H-NS (Histone-like nucleoid structuring protein) and FIS (Factor for
inversion stimulation) (Betermier et al, 1993; Ranquet et al, 2005). Entry into the lytic
cycle is marked by multiple rounds of replicative transposition and concomitant
packaging into about 100 viral particles (Chaconas et al, 1981). Mu uses the host RNA
polymerase with the primary sigma factor σ70 to transcribe its genes (Toussaint and
Lecocq, 1974). Gene expression during the lytic cycle occurs in three phases: early,
middle and late and is characterized by a highly controlled regulatory cascade (Marrs and
Howe, 1990). The early genes are transcribed from the early promoter Pe, the middle
genes from middle promoter Pm and the late genes from the late promoters Plys, PI, PP and
Pmom (Margolin et al, 1989) (Figure 8). Thus, the lytic development of phage Mu presents
an excellent model system to study the structural, mechanistic and functional aspects of
both transposition and transcription activation.
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Reprinted with permission from American Society for Biochemistry and Molecular biology. Kumaraswami M, Howe
MM, Park HW. Crystal structure of the Mor protein of bacteriophage Mu, a member of the Mor/C family of
transcription activators. J Biol Chem. 2004, 279(16): 16581-90.

The solid line represents the 36.7-kb Mu DNA with marks at 5-kb intervals. The ends of the genome are defined by the
attachment site, attL and attR. The rectangle at the right represents attached host DNA present in phage particles. The
location of Mu genes and their functions are given above the genome line. The locations of the promoters, the direction
of transcription are shown below the line. The curved arrows and the plus signs indicate the transcriptional control
points of the actiavtors Mor and C at their respective promoters.

Figure 8: Transcriptional organization of the Mu genome.

Expression of the early operon from Pe is independent of de novo protein
synthesis and phage replication and is stimulated by IHF (Wijffelman et al, 1974; Krause
and Higgins, 1986; Marrs and Howe, 1990). The early promoter Pe has a good match to a
typical E.coli promoter with recognizable -10 and -35 elements for recognition and
binding by the bacterial RNAP (Krause and Higgins, 1986); it does not require the
presence or function of an activator. Transcription from the early promoter can be
detected within a few minutes of infection and induction (Wijffelman and van de Putte,
1974) and results in the expression of early genes encoding proteins functioning in the
lysis/lysogeny decision (Giphart-Gassler et al, 1981; Van Leerdam et al, 1982; Goosen
and van de Putte, 1984; Krause and Higgins, 1984), the integration and replication
functions A and B (Wijffelman and Lotterman, 1977; Toussaint et al, 1983), the Cro-like
repressor Ner (van Leerdam et al, 1982) and a number of non-essential and
growth-enhancing functions. This transcript also encodes the activator for Pm, the middle
operon regulator Mor (Mathee and Howe, 1990).
The middle and four late promoters have recognizable -10 hexamers, but lack
sequences similar to the canonical -35 promoter element. Thus, they are subject to
positive regulation by activator proteins (Figure 9). Transcription from these promoters
depends on phage-encoded transcription activator proteins: Mor for Pm and C for the late
promoters (Margolin et al, 1989; Mathee and Howe, 1990; Stoddard and Howe, 1990).
Middle operon transcription initiating at Pm requires phage replication and the
early gene product Mor. The middle transcript is detectable about 8 minutes into the lytic
cycle and increases steadily thereafter (Stoddard and Howe, 1989; Marrs and Howe,
1990; Stoddard and Howe, 1990; Mathee and Howe, 1990). Sequence analysis of the
middle operon led to the prediction of five open reading frames with the most distal one
encoding C, the activator of late transcription (Hattman et al, 1985; Heisig and Kahmann,
1986; Margolin and Howe, 1986; Stoddard and Howe, 1987). With the exception of C,
the other proteins encoded by the open reading frames of the middle operon do not seem
to be important for phage development (Mathee and Howe, 1993).
The genes of the late phase, expressed from the C-regulated late promoters (Plys,
PI, PP and Pmom) encode functional components for phage morphogenesis, cell lysis and
DNA modification. They are expressed about 20 minutes after induction and continue till
lysis (Margolin et al, 1989; Stoddard and Howe, 1989). These promoters share an
imperfectly conserved sequence overlapping the position of the absent -35 consensus
hexamer (Stoddard and Howe, 1989; Margolin et al, 1989; Marrs and Howe, 1990).
The roles of specific Mu late genes are as follows:
1. The first gene of the late phase, lys, promotes cell lysis at the end of the lytic
cycle (Faelen and Toussaint, 1973).
2. Genes D-J as per their organizational positions on the Mu genome are required for
phage head formation (Shore and Howe, 1982; Grundy and Howe, 1985).
3. Genes K-W as per their positions on the genome, encode the structural and
functional components of the tail assembly process (Grundy and Howe, 1985).
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Reprinted with permission from Kumaraswami M. Structural and functional characterization of Phage Mu Mor gene. 2005,
University of Tennessee Health Science Center, Memphis.

The middle promoter and the four late promoters are aligned based on Mor/C binding sites, -10 hexamers and the transcription
start sites. The dolid bars denote the region protected by Mor and C in their respective promoters. The imperfect dyad
symmetry element within the protein footprints is indicated by inverted arroes. The -10 hexamer is marked by a box around it.
The curved arrow represents the transcription start site +1. The dots denote 10-bp intervals.

Figure 9: Mu middle and late promoters.

4. The host range for infection is specified by the products of the genes S, S’, U and
U’ which are located within and overlapping the invertible G segment (Grundy
and Howe, 1984). Different tail fiber proteins result from the two alternative
arrangements of these genes, thus specifying adsorption to different
lipopolysaccharide receptors (Sandulache et al, 1984) on the cell surface of either
E.coli K12 or a heterogenous group of enteric bacteria (Kamp et al, 1978; van de
Putte et al, 1980).
5. The inversion of the G segment is catalyzed by the site-specific recombinase
encoded by the gin gene (Kahmann et al, 1985).
6. The mom gene encodes a DNA modification function which converts about 15%
of all adenines to α-N-(9-β-D-2’-deoxyribofuranosylpurin-6-yl) glycinamide,
which confers resistance of the infecting Mu DNA to cleavage by a wide range of
restriction enzymes (reviewed by Kahmann, 1983; reviewed by Hattman, 1999).
7. The com gene encodes the small zinc-coordinating translational activator of mom
gene expression, Com (Wulczyn et al, 1989; Witkowski et al, 1995; Wulczyn and
Kahmann, 1991).
The middle promoter of bacteriophage Mu, Pm
A strong basal promoter should ideally be close to the consensus sequence
elements for efficient RNAP binding to initiate transcription. The region downstream of
the -10 hexamer including the transcription start site should be prone to melting, and the
upstream elements should contribute to RNAP binding. The importance of the spacer
region is underscored by the fact that it should be of permissible length and show
functional significance for productive RNAP binding, melting of the promoter region and
conformational changes in RNAP required for efficient initiation. While some promoters
in E. coli are active without the help of any accessory factors, many promoters need
additional factors for function (Collado-Vides et al, 1991). The common feature of these
promoters is the presence of a proximal site, usually between -20 and -70, facilitating the
binding of activators specific for the promoters. Thus, it seems that the entire promoter
region from about -70 to the transcription start site is functionally important contributing
to various factors for productive transcription. Deletion and footprinting analyses in the
promoter region revealed that sequences upstream of -62 and downstream of +10 are
dispensable for promoter activity in terms of binding of Mor and RNAP although binding
of the α-CTD to an UP-like element leads to increased levels of transcription (Ma and
Howe, 2004).
The initiation of transcription at Pm represents an important regulatory step in the
production of viable phage progeny in the lytic. Transcription from Pm is dependent on
phage replication, thus coordinating Mu DNA synthesis, the production of proteins for
cell lysis and Mu genome packaging. The product of the middle operon, C protein
triggers the expression of late genes which result in packaging of the Mu DNA into phage
particles and cell lysis. The middle promoter Pm is a model promoter for positive
regulation of transcription. It has a recognizable -10 hexamer, but lacks similarity to the
consensus -35 hexamer. Initiation of transcription from this promoter depends on the
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presence of RNAP holoenzyme and the phage-encoded activator Mor, both in vivo and in
vitro (Mathee and Howe, 1990; 1993). Mutational analysis revealed that there are three
regions important for promoter activity:
1. The -10 region: involved in binding of the σ70 subunit of RNAP.
2. An imperfect dyad symmetry element: DNase I footprinting analysis showed that
Mor protects Pm sequences from -33 to -56 (Kahmeyer-Gabbe and Howe, 1996).
An imperfect dyad symmetry element with a 6-bp spacer was identified between
-36 and -51 (AGTAAagccggTTAAT).
3. Region -29 to -31: between the Mor footprint and -10 region, which usually
overlaps -35 consensus, has no similarity to the consensus. Both up and down
mutations in this region had no detectable effect on Mor binding. DNase I
footprinting with Mor resulted in hypersensitivity to cleavage between -29 and
-32, indicating an alteration of DNA structure. Hypersensitivity to the
single-strand specific agent potassium permanganate was also detected at -32 and
-33 during simultaneous binding of Mor and RNAP holoenzyme. Thus, this
region was hypothesized to undergo a conformational change during protein
binding and promoter activation causing a distortion or unwinding necessary for
precise alignment of Mor and RNAP (Artsimovitch and Howe, 1996).
The middle operon regulator Mor
The most distal ORF of the early operon encodes a small protein of molecular
mass 14.7 kDa, which activates transcription from the middle promoter Pm; hence, it is
called the Middle operon regulator protein Mor. It is the only Mu-encoded protein
required for transcription of the middle operon both in vivo and in vitro (Mathee and
Howe, 1990; 1993). It is a 129 amino acid , sequence-specific DNA-binding protein
(Mathee and Howe 1990) with an isoelectric point of 6.3. The N-terminus of Mor is
composed of a mixture of acidic and hydrophobic residues, whereas the C-terminal
region is rich in basic residues, characteristic of a DNA-binding region. Mor is closely
related and highly homologous to the C protein of bacteriophage Mu (about 31%
sequence similarity) (Mathee and Howe, 1990) and they carry out similar functions. They
are the founding members of a new family of transcription factors called the Mor/C
family; they exhibit little or no homology to any other proteins except for Mor/C proteins
in Mu-like prophages identified in bacterial genome sequences. Both proteins bind to
DNA as dimers to a site located immediately upstream of the -35 region in their
respective promoters. Consistent with their dimeric nature, an imperfect dyad symmetry
element is present in the binding sites of both Mor and C. Like Mor, C protein also has an
acidic and hydrophobic N-terminal region and a basic C-terminal region.
The presence of an imperfect dyad symmetry element within the Mor-binding site
(Artsimovitch and Howe, 1996) and the observation of dimeric species in glutaraldehyde
cross-linking experiments suggested a dimeric nature for the protein. Mor binding
introduces a distortion in the promoter DNA in the form of a bending angle of ~ 40° upon
binding (Mo, 2004). Footprinting studies and mutational analysis of the middle promoter
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identified the region from -36 to -51 of Pm as Mor binding site. The Mor binding site is
characterized by the presence of 6-bp long AT-rich imperfect dyad symmetry element
that is separated by a 4-bp long GC-rich spacer (Artsimovitch and Howe, 1996). Middle
promoter activation by Mor requires the C-terminal domains of both alpha and sigma
subunits of RNA polymerase (Artsimovitch et al, 1996). Experiments with purified Mor
and α-CTD proved that Mor binding to Pm is strengthened by the addition of α-CTD and
Mor might use its interaction with the α-CTD to recruit the RNA polymerase to the
promoter through a synergistic stabilization of various protein-DNA interactions.
Consistent with this, an UP-like element located 7-8 bp upstream of Mor binding site was
identified as a binding site for the α-CTD of RNAP (Ma and Howe, 2004). Based on the
above findings, a working model was proposed in which Mor binds to the promoter in a
region centered at -43.5 and carries out transcription activation by recruiting RNA
polymerase through its interaction with the C-terminal domains of the α and σ subunits of
RNA polymerase (Figure 10) (Artsimovitch and Howe, 1996).
Solving the crystal structure of Mor at a resolution of 2.2 Å was a landmark event,
giving great insights into our understanding of the structural and functional significance
of different regions of Mor with respect to Pm and RNAP interactions (Kumaraswami et
al. 2004). The ribbon representation of the Mor dimer is shown in Figure 11. The crystal
structure of Mor revealed that the Mor monomer is folded into two independent domains.
The N-terminal domain is composed of two α-helices, α1 and α2, running in opposite
directions with an angle of 120° to each other. The C-terminal domain contains three
helices, α3, α4, and α5 folded into the Helix-turn-Helix (HTH) DNA-binding motif. The
N- and C-terminal domains are connected by a β-strand linker (Figure 11). Three glycine
residues (Gly65, Gly66, and Gly67) N-terminal to the β-strand and one glycine (Gly74) Cterminal to it potentially create two flexible junctions between the N- and C-terminal
domains. Helices α1 and α2 of the N-terminal domain and the β-strand, form the
structural elements for Mor dimerization and are arranged with respect to the 2-fold
symmetry-related axis to form an intertwined four-helix bundle with a pair of antiparallel
β-strands capping one end of the bundle (Kumaraswami et al, 2004). At the Mor dimer
interface, many hydrophobic residues, including leucines and isoleucines, interact with
their symmetry-related equivalents in four layers of hydrophobic interactions forming an
extensive hydrophobic core, thus stabilizing the dimer. The three helices, α3, α4, and α5,
in the Mor C-terminus form a three-helix bundle with a classical helix-turn-helix
DNA-binding motif. In Mor, helix α 3 serves the scaffolding role anchoring and
stabilizing the other helices. Mor helices α 4, α 5 and the turn between them contain
conserved residues characteristic of the DNA-binding HTH motif.
Comparison of the structural elements with other HTH proteins provided evidence
for an "ends-on" base recognition, with helix α5 serving as the Mor recognition helix
(Kumaraswami et al, 2004). Modeling of the Mor-Pm interaction led to the prediction that
Mor would bend the Pm sequence away from Mor. This can place the two adjacent major
grooves of Pm in an optimum position to interact with the HTH domains of the Mor dimer
at the two ends (Figure 12). Thus, conformational changes in both DNA and Mor are
predicted to take place to achieve optimum structural and functional interactions
(Kumaraswami et al, 2004).
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Figure 10: Diagrammatic representation of protein-protein and protein-DNA interactions
in the middle promoter open complex.
Middle promoter is represented by the horizontal line. The dyad symmetry element for
Mor binding is shown as inverted arrows; the spacer distortion from -34 to -32 by open
diamond; the strand separartion in the open complex from -12 to +1 by an open oval. The
black rectangles represent the interfaces of Mor-RNAP interactions.
Reprinted with permission from American Society for Biochemistry and Molecular
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol
Chem. 2004, 279(16): 16581-90.
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Figure 11: Ribbon representation of Mor dimer.
It is viewed parallel to the crystallographic two-fold axis. One monomer is in yellow and
the other in red. The secondary structure elements of the second monomer are identified
with a prime.
Reprinted with permission from American Society for Biochemistry and Molecular
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol
Chem. 2004, 279(16): 16581-90.

26

Figure 12: Proposed model for DNA-binding by Mor.
The dimerization domains are represented as cylinders for α-helices and arrows for βstrands. Mor HTH motifs are shown as ribbon representations. The arrows show the
proposed interactions of the HTH motifs with the two adjacent major grooves. Panel B
shows the DNA with a ∼40° bend as the HTH domains dock into the major grooves
(Kumaraswami, 2005).
Reprinted with permission from American Society for Biochemistry and Molecular
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol
Chem. 2004, 279(16): 16581-90.
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Chapter 2: Mutational analysis of Pm and their possible
effects on binding and activation by Mor
Introduction
Bacteriophage Mu is a temperate phage with its life cycle divided into two
phases: lytic and lysogenic phases (Howe, 1973; Hattman, 1999). Transcription during
the lytic cycle has a regulatory cascade composed of three phases of gene expression:
early, middle and late (Marrs and Howe, 1990). Thus, the life cycle of phage Mu presents
a valuable model system for studying transcriptional regulation (Howe, 1973; Hattman,
1999). The early promoter Pe, has both -10 and -35 hexamers (Krause and Higgins,
1986), a typical promoter architecture of basal promoters. In contrast, the middle
promoter Pm, and the four late promoters are model promoters for positive regulation;
they have recognizable -10 hexamers but lack -35 hexamers (Margolin et al, 1989;
Stoddard and Howe, 1990). Transcription from these promoters requires phage-encoded
activators. Transcription from Pm requires a product of the early transcript, Mor and
transcription from the late promoters requires a product of the middle transcript, C
(Margolin and Howe, 1990; Mathee and Howe, 1993).
The middle operon regulator (Mor) protein is the product of the last gene in the
early transcript and it is the only Mu protein required for transcription from the middle
promoter Pm. Mor is a 129-amino acid long, dimeric, sequence-specific DNA-binding
protein (Mathee and Howe, 1990; Kahmeyer-gabbe and Howe, 1996; Artsimocitch and
Howe, 1996). Mor does not share amino acid sequence similarity with other families of
transcription factors and, together with the closely related phage-encoded activator C,
defines a new family of transcription factors called the Mor/C family of transcription
activators (Kumaraswami et al, 2004).
The dimeric nature of Mor is supported by the following evidence:
a) Extensive mutagenesis of the Mor-binding site in Pm revealed an imperfect dyadsymmetry element with a central 4-bp spacer, suggesting the requirement of a
dimeric form of Mor to recognize the symmetrical sequences (Artsimovitch and
Howe, 1996).
b) Glutaraldehyde cross-linking experiments identified a cross-linked species
corresponding to the size of a Mor dimer (Artsimovitch and Howe, 1996).
c) Mutational analysis of the Mu late promoter, Plys and SMCC cross-linking
experiments with the Mu late gene activator C, a closely-related homologue of
Mor, provided evidence for a dimeric form of C bound to a dyad-symmetrical
binding site (Chiang and Howe, 1993; Ramesh and Nagaraja, 1996; Jiang, 1999;
Zhao, 1999).
d) The crystal structure of Mor captured the dimeric form of Mor through the twofold crystallographic symmetry axis (Figure 11) (Kumaraswami et al, 2004).
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Mor recognizes and binds to a 16-bp region in Pm located at -36 to -51 bases
upstream of the start site +1 (Artsimovitch and Howe, 1996). Mor activates transcription
from Pm by recruiting the host RNA polymerase to the middle promoter (Mo, 2004). The
basis for Mor-dependent Pm activation include protein-protein interactions between Mor
and the C-terminal domains of the α and σ subunits of RNA polymerase which are
required for efficient recruitment of RNA polymerase to Pm (Artsimovitch et al, 1996;
Ma and Howe, 2004; Mo, 2004).
Mutational analysis of Pm revealed three important regions for its function:
1. The -10 region which is important for Pm-σ interactions (Artsimovitch and Howe,
1996).
2. The 16-bp Mor-binding site located immediately upstream of the missing -35
hexamer from -36 to -51. Extensive mutagenesis of Pm defined two AT-rich 5-bp
long repeats in the imperfect dyad symmetry element that are separated by a
GC-rich 5-bp spacer (Artsimovitch and Howe, 1996).
3. An UP-like element situated upstream of the Mor-binding site from -54 to -62
comprising the binding element for the α-CTD of RNA polymerase (Ma and
Howe, 2004).
The crystal structure of His-tagged Mor at a resolution of 2.2 Å revealed a
dimeric Mor protein with the two subunits being related to each other by a
crystallographic two-fold symmetry axis. The first 26 amino acids of the N-terminus and
the last 9 amino acids from the C-terminus were not visible in the structure. The Mor
monomer is folded into two recognizable independent domains: an N-terminal
dimerization domain and a C-terminal helix-turn-helix DNA-binding domain
(Kumaraswami et al, 2004).
The N-terminal domain is composed of two α-helices, α1 and α2. These two
helices run in opposite directions with an angle of 120◦ relative to each other. The
interlocking of N-terminal helices of both monomers against each other along with the
anti-parallel interactions between the β-strands constitutes the dimerization domain. At
the Mor dimer interface, many hydrophobic residues interact with their symmetry-related
equivalents. Key residues involved in dimerization include several leucines of helix α1
and a mixture of isoleucines and leucines of helix α2 (Kumaraswami et al, 2004).
The C-terminal domain of Mor contains three helices, α3, α4 and α5, which are
folded into the classic DNA-binding HTH motif. The specific positioning of the two
HTH motifs at the opposite ends of the Mor dimer would structurally complement their
interaction with the bases in the symmetry element. In Mor, helix α3 functions as the
structural scaffold anchoring α4 and α5. The recognition helices α5, and the turn between
α4 and α5 contain conserved residues characteristic of the DNA-binding HTH motif and
structural coordinates similar to those of HTH proteins with an “ends-on” base
recognition.
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The N- and C-terminal domains are connected by a β-strand linker. Three glycine
residues (G65, G66 and G67) are located in the loop N-terminal to the β-strand and one
glycine (G74) is present in the C-terminal loop immediately after the β-strand, potentially
creating two flexible junctions between the N- and C-terminal domains. Docking studies
with a 16-bp B-DNA structure indicated that the two HTH motifs are located too far apart
to interact with two adjacent major grooves in linear DNA. In order to overcome the
calculated 9Å discrepancy, it was proposed that both protein and DNA might need to
undergo conformational changes to allow Mor binding to DNA (Kumaraswami et al,
2004). Consistent with this, a structural distortion with a 45° bending angle was observed
in Pm upon Mor binding (Mo, 2004). The highly conserved glycines flanking the β-strand
are hypothesized to be the pivot points for the conformational changes in Mor.
Another interesting feature observed in His-Mor structure is the location and
direction of the side chains of Y70 and Q68 in the β-strand region. These two side chains
are protruding away from the molecule in upward direction and not involved in any intra
or inter molecular interactions. In our current working model, in the presence of DNA,
conformational changes originating from glycines (G65, G66, G67 and G74) place the Nterminus of the recognition helix α5 in position to interact with the bases in the adjacent
major grooves. This arrangement of protein and DNA would place the β-strand region
under the minor groove of the central spacer between the 6-bp inverted repeats, such that
the two residues Y70 and Q68 might interact with the minor groove of the spacer (Figure
12).
The current work
Sequence-specific DNA-binding proteins read the information in DNA through
the two structural features of a B-form DNA: major groove and minor groove. In most
cases, the specific recognition of DNA takes place principally in the major groove due to
its better accessibility and greater information content (Bewley et al, 1998; Jones et al,
1999). The minor groove has a minor role in such interactions because of its narrower
and deeper nature (Travers, 1995). Proteins with such dual binding mode generally have
a HTH DNA-binding motif, which is used in major groove interactions (Jones et al,
1999).
The crystal structure of Mor identified two regions as possible candidates to make
DNA contacts (Kumaraswami et al, 2004). The HTH motifs located in the C-terminal
domain of Mor dimer are predicted to make interactions in the major groove of dyad
symmetry element and the mutational analysis results were in agreement with the
structural predictions. The HTH motif-major groove interactions place the β-strand linker
region in the proximity of the minor groove of the spacer region located on the same face
of the two major grooves.
One remarkable feature of the β-strand linker region is the side chains of Q68 and
Y70 that are protruding away Mor, but towards the possible direction of DNA indicating
possibility of minor groove interactions (Figure 13). The primary sequence comparisons
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A

B

Figure 13: Representation of Q68 and Y70 and possible Mor-DNA contacts.
A) Representation of Q68 and Y70. The side chains of Q68 and Y70 from different
monomers are color-coded (red from the dark gray monomer and green from the gray
monomer).
B) Possible Mor-DNA contacts. His-Mor dimer structure is as ribbons with the
monomers in red and yellow; DNA in magenta. Green arrow represents the predicted
Mor-minor groove interactions as a result of the Mor-major groove interactions which are
shown as black arrows.
Reprinted with permission from Kumaraswami M. Structural and functional
characterization of Phage Mu Mor gene. 2005, University of Tennessee Health Science
Center, Memphis.
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of the amino acids in the β-strand linker region of the members of Mor/C family revealed
a high degree of sequence homology at these two positions indicating the importance of
those to Mor function and suggesting a common function in all the members.
Comprehensive mutational analysis of Q68 and Y70 and inhibition assay with a
GC-specific minor groove binding drug, chromomycin elucidated the important
contribution of the residues (Kumaraswami, 2005). As in case of most of the transcription
regulators, Mor needs to bind DNA in order to carry out transcription activation from Pm.
The mutant proteins failed to activate transcription underlining the importance of the
side chains of Q68 and Y70 for Mor function, possibly by participating in the DNAbinding function (Kumaraswami, 2005). Chromomycin inhibited Mor binding to
promoter sequences at concentration as low as 2 μM indicating the importance of minor
groove to Mor binding. Chromomycin was unable to completely disrupt the preformed
Mor-DNA complex even at concentrations as high as 50 μM, thus, suggestive of Morminor groove interactions. The inhibition might be due to the disruption of Mor-minor
groove contacts by chromomycin binding to the GC-rich spacer sequences or the
structural effects extending into the flanking major grooves as a result of chromomycin
binding to the minor groove.
Protein-minor groove contacts have been classified into three major categories:
intercalation, specific interactions and indirect readout. To gain access to the information
content of narrower minor groove, protein pry open the minor groove by inserting the
side chains of amino acids between adjacent bases by interdigitations which unstack the
adjacent bases and introduce a kink or bend in the direction of the duplex DNA. In
support of intercalation, a bending angle about 45˚ was observed in Pm upon Mor
binding. Though the deficiency of chemical features presented by the minor groove is
generally considered to be insufficient for specific recognition (Travers, 1995), some
structures revealed specific contacts between different side chains and base edges
exposed in the minor groove through hydrogen bonding, van der waals interactions, and
water-mediated contacts (Moravek, 2002). In most cases it occurs in tandem with
intercalation as it facilitates the specific interactions by wedging open the minor groove.
Two pieces of evidence discounted the possibility of such specific interactions between
Mor and the minor groove bases of the spacer region. First, single base substitutions
identified in the spacer region of Pm appeared to be less detrimental to Mor binding
compared to the mutations in the symmetry element. The tolerance to various mutations
in the spacer region indicates the lesser role played by this region. Second, the conserved
nature of Q68 and Y70 disfavors the specific contacts between identical side chains and
chemically dissimilar spacer sequences of middle and four different late promoters. It is
observed that amino acids that make specific contacts with different sequences are
generally not conserved. It might be useful to test the effect of symmetrical substitutions
in the spacer region on Mor binding. In indirect read-out, the conformational flexibility of
the non-contacted bases in a protein binding site influences the affinity of a protein-DNA
complex (Perez Martin J and de Lorenzo V, 1997; Mauro et al, 2003). Structural
alterations in the DNA are crucial for the proper spatial relationship between the protein
and DNA. Considering the high flexibility predicted for the GC-rich spacer region
(Gabrielian and Pongor, 1996), indirect readout between Mor and the minor groove of the
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spacer region is a possibility. It is possible that DNA oscillates between different
conformations due to the flexibility conferred upon by the GC-rich spacer region and
interactions between Mor and the minor groove sequences might trap the DNA in the
bent conformation.
Deletion mapping and DNase I footprinting revealed that Mor protects Pm
sequences -33 to -56, thus indicating that Mor-binding sequence in Pm overlaps with this
region (Kahmeyer-Gabbe and Howe, 1996). Thus, Mor binds to the promoter in a region
centered at -43.5 and carries out transcription activation by recruiting RNA polymerase
through its interaction with the C-terminal domains of the α and σ subunits of RNA
polymerase (Artsimovitch and Howe, 1996; Ma, 2004). Also, previous mutational
analysis of Pm identified two mutations upstream of the Mor-binding site, G-57T with
twice the activity of the wild-type and A-54T with half the wild-type activity, suggesting
that sequences upstream might play a role in Pm function (Artschimovitch, 1996).
The goal of this study is to study the effect of mutations in Pm from -30 to -57
spanning the region previously shown to be important for Mor- Pm interactions. This
would also help us to optimize the Mor-binding region of Pm useful for crystallographic
studies of Mor-DNA duplex. Extensive mutagenesis studies were also conducted to study
the effect of mutations in the spacer region of -42 to -45 because this is the spacer region
in which the side chains of Y70 and Q68 from the β-strand protrude into. This was done
to test if Mor-DNA interactions in the minor groove occurred through specific base
contacts. In addition to the extensive mutatgenesis of the spacer region, targeted
mutagenesis was carried out for the entire region with specific mutations chosen for each
position as given in Table 1. The rationale behind each of the specific mutation is
discussed in the Table 2.
For the spacer region, mutagenesis was done with degenerate oligonucleotides for
the 4 positions in pair and as a group. Plate phenotyping of the mutants, gel shift assays
for the mutants with wild-type His-Mor and β-galactosidase assays were used to
differentiate the effect of the mutations. Gel mobility shift assays were done with
oligonucleotide probes. The length of the oligonucleotide probe needed for efficient Mor
binding was first standardized and various mutations were then introduced into the
specific length probe.
The center of the Mor-binding site in Pm is -43.5 position between -43 and -44
from the transcription start site of +1. The mutations that we made either introduced
symmetrical changes in positions that were not symmetrical centered at -43.5 or disrupted
the symmetry by introducing a different base. The symmetrical changes refer to positions
the same number of bases from the center of -43.5. As Mor binds Pm as a dimer, these
mutations would help us study the effect of symmetry element for binding of the dimer.
They would also help us study the contribution of the specific bases for Mor binding. The
contribution of the bases to the stability of Mor-Promoter duplex can be studied by
mutagenesis of this region of Pm.
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Table 1: Specific mutations of the promoter.
A comprehensive table which gives all the mutations that were done for Pm spanning the
region from -57 to -30 with respect to the transcriptional start site of +1. The second row
gives the bases in the wild-type sequence of Pm and their positions are numbered above
them. Following that, the 29 mutations are given sequentially. The mutation numbers are
in the first column and the letters in red are the mutations that were introduced at that
position. The unfilled boxes indicate that the bases in these positions are same as that in
the wild-type promoter. The blue underlined bases indicate the dyad-symmetry element
predicted to interact with Mor in the major groove. The purple letters indicate the
position of the bases of the minor groove spacer region.
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Table 2: Mutations of Pm and the rationale behind each of them.
Mutation
numbers
Mutation 1

Mutation

Rationale behind the mutation

-46 A to C

Mutation 2

-41 G to T

Mutation 3

-48 A to C and -39 T to G

Mutation 4

-37 A to C

Mutation 5

-52 C to G

Mutation 6

-52 C to A and -35 C to T

Mutation 7

-34 C to T

Mutation 8

-53 A to G

Mutation 9

-33 G to T

Mutation 10

-54 A to C

Mutation 11

-32 G to T

Mutation 12

-31 C to A

To make symmetrical* substitution
corresponding to -41G.
To make symmetrical substitution
corresponding to -46A.
To maintain symmetry, but with a GC
combination at these positions. To test if
specific bases are important or is it just a
factor of symmetry.
To make symmetrical substitution
corresponding to -50G. Previous data**
recorded slightly higher in vivo activation
as compared to wild-type.
To make symmetrical substitution
corresponding to -35C.
To make these positions symmetrical with
respect to each other with an AT
combination. Previous data for -35 C to T
recorded slightly higher in vivo activation
as compared to wild-type.
To make symmetrical substitution
corresponding to -53A. Previous data
recorded slightly higher in vivo activation
as compared to wild-type.
To make symmetrical substitution
corresponding to -34C. Previous data
recorded slightly higher in vivo activation
as compared to wild-type.
To make symmetrical substitution
corresponding to -54A. Previous data
recorded slightly higher in vivo activation
as compared to wild-type.
To make symmetrical substitution
corresponding to -33G
To make symmetrical substitution
corresponding to -55A. Previous data
recorded slightly higher in vivo activation
as compared to wild-type.
To make symmetrical substitution
corresponding to -56T. Previous data
recorded twice the wild-type activity.
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Table 2 (continued).
Mutation
numbers
Mutation 13

Mutation

Rationale behind the mutation

-56 T to A and -31 C to T

Mutation 14

-57 G to T

Mutation 15

-57 G to T and -30 T to A

Mutation 16

-50 G to T and -41 G to T

Mutation 17

-50 G to T and -46 A to C

Mutation 18

-42 through -45 AAAA

Mutation 19

-42 through -45 TAAT

Mutation 20

-42 through -45 GGCC

Mutation 21

-42 through -45 GGGG

Mutation 22

-57 G to T, -53 A to G
and -31 C to T

Mutation 23

-57 G to T and -53 A to G

To maintain the symmetry of mutation 12
but by swapping positions of A and T.
substitution at -31 gave twice the wild-type
activity as compared to wild-type.
Previous data revealed twice the activity as
compared to wild-type sequence.
Previous data of substitution at -57
revealed twice the activity as compared to
wild-type sequence. To make symmetrical
substitution corresponding to -57 when
changed to T.
To make symmetrical substitutions at both
positions corresponding to -37A and -46A
respectively such that the 6 base-pair dyad
symmetry is perfect and AT-rich.
To make symmetrical substitutions at both
positions corresponding to -37A and -41G
respectively such that the 6 base-pair dyad
symmetry is perfect and AT-rich except at
positions -41 and -46, where it is GC-rich.
Making these positions A-rich to test if this
mutation makes any change in the minor
groove dimensions that could affect Mor
binding or is it just the specific bases that
are important in the minor groove spacer.
Making these positions AT-rich, but
maintaining the wild-type symmetry. To
test if this mutation makes any change in
the minor groove dimensions that could
affect Mor binding.
Making the spacer region symmetrical
centered at -43.5.
Making it G-rich to test if specific bases are
important in the minor groove or is it just
the minor groove dimensions.
Previous data with the specific substitutions
at the 3 positions gave twice the wild-type
activity. To test if these substitutions
together are cumulative in their effect or
otherwise.
A subset of mutation 22 with the same
rationale.
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Table 2 (continued).
Mutation
numbers
Mutation 24

Mutation

Rationale behind the mutation

-57 G to T and -31 C to T

Mutation 25

-53 A to G and -31 C to T

Mutation 26

-50 G to T

Mutation 27

-48 A to T and -39 T to A

Mutation 28

-49 to -47 ATT and
-40 to -38 AAT

Mutation 29

-50 to -46 TATTC and
-40 to -38 AAT

A subset of mutation 22 with the same
rationale.
A subset of mutation 22 with the same
rationale.
To test the individual contribution by -50T
from mutation 17, as mutation 17 gave
twice the wild-type binding by His-Mor in
a gel shift in vitro binding assay.
To maintain symmetry at these positions
with respect to each other but by swapping
the bases from wild-type sequence to test if
binding by wild-type His-Mor is affected
by symmetry or the specific bases in these
positions.
To maintain symmetry at these positions
with respect to each other but by swapping
the bases from wild-type sequence to test if
binding by wild-type His-Mor is affected
by symmetry or the specific bases in these
positions.
To test effect of mutation 28 in
combination with mutation 17 (gave twice
the wild-type promoter binding by His-Mor
in the gel shift assay).

* Symmetry centered at -43.5.
** Previous data - Artsimovitch, 1996.
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Materials and methods
Media, chemicals and enzymes
Protein over-expression and routine cell growth were done in LB medium
(Howe, 1973), whereas cultures for β-galactosidase assays were grown in minimal
medium with casamino acids (M9CA) (Margolin et al, 1989). Bacto agar, Bacto tryptone
and Bacto yeast extract used for LB medium were purchased from Difco Laboratories
and sodium chloride from Fisher Scientific. MacConkey lactose plates with 25 g/L of
MacConkey agar (Difco) and 25 g/L of MacConkey agar base (Difco) was used for plate
phenotyping. Chloramphenicol and ampicillin were purchased from Sigma. Isopropyl-βD-thiogalacto-pyranoside (IPTG) was from US Biologicals and o-nitrophenyl-βgalactopyranoside (ONPG) was from American Bioorganics. Acrylamide, bisacrylamide,
40% acrylamide/bis-acrylamide (29:1) solution, tetramethylethylenediamine (TEMED)
and ammonium persulfate (APS)were purchased from BioRad. Chloroform and glycerol
were obtained from Fisher Scientific. Imidazole was purchased from Sigma and sodium
dodecyl sulfate (SDS) was from BioRad. Trizma base was from Sigma. Glacial acetic
acid, ethylene diamine tetraacetic acid (EDTA) and boric acid were purchased from
Fisher Scientific. D-Glucose, M9 salts, thiamine, biotin, potassium chloride,
dithiothreitol, IGEPAL CA-630 and Ficoll-400 were all purchased from Sigma. Glycine
and β-mercaptoethanol were from BioRad. Casamino acids was from Difco and sodium
carbonate was from JT Baker. Magnesium sulfate, calcium chloride, monosodium and
disodium phosphates were from Sigma. Absolute ethanol and 95% ethanol were from
AAPER Alcohol and Chemical Co., Shelbyville, KY. Seakem ME and LE grade agarose
were from Lonza, Rockland Inc. The bradford protein assay reagent and Bio-safe
Coomassie stain for protein gels were from BioRad. Dimethyl sulfoxide (DMSO) for
freezing the bacterial strains was from Sigma. The restriction enzymes BamH1 and
EcoR1 were from New England Biolabs. Taq polymerase was from Roche Diagnostics
and T4 DNA ligase was from New England Biolabs. T4 polynucleotide kinase (PNK)
and dNTPs were obtained from Promega Corporation. Shrimp alkaline phosphatase
(SAP) was purchased from Roche Diagnostics. [γ P32]-ATP was obtained from Perkin
Elmer Life Science, Boston, MA. Talon spin columns used for protein purification were
from Clontech. Miniprep and midiprep kits for small and large scale plasmid extraction
respectively were purchased from Promega Corporation. Kit for purification of PCR
products was obtained from Qiagen. Slide-A-Lyzer dailysis cassette (10-kDa cutoff) for
protein purification was from Pierce. Columns for purification of oligo probes used in gel
shifts, G25 (for oligonucleotides from 10-20 bases in length) and G50 (for
oligonucleotides 20-50 bases in length) were from GE Healthare. BioMax MR films for
exposing the gel shift gels were from Kodak.
Bacterial strains and plasmids
The host strain background for most of the plasmid constructions and in vivo
assays was Escherichia coli K-12 strain MH13312 (mcrA Δpro-lac thi gyrA endA hsdR
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relR supE44 recA / F' pro+ lacIQ1 ΔlacZY), a derivative of JM109 carrying an F’ plasmid
deleted for both lacZ and lacY and expressing higher than normal levels of Lac repressor
(Artsimovitch and Howe, 1996). It has no antibiotic resistance. Strain MH13435 was
made by transforming plasmid pIA14, that has wild-type Pm sequence from -61 to +10
fused to lacZ, into MH13312. Plasmid pIA14 has the ampicillin resistance gene. Strain
MH13418 was made by transforming plasmid pIA69, which has the his-mor gene under
the control of IPTG-inducible PlacUV5 promoter, into MH13312. This was used as a host
for transformation for phenotypic and quantitative assays of the ability of Mor to activate
transcription from the various mutations introduced into Pm. Plasmid pIA69 has the
chloramphenicol resistance gene. Strain MH13315 with plasmid pIA12, which does not
have a wild-type promoter, Pm was used as a vector for all clonings to facilitate selection
of clones. Plasmid pIA12 has the ampicillin resistance gene. Strain MH13355 is the
protein expression strain, containing λDE3 that encodes T7 RNA polymerase used for
protein over-expression and detection of wild-type protein His-Mor.
Oligonucleotide synthesis
Oligonucleotides were synthesized by Integrated DNA Technologies Inc. on a
commercial nucleic acid synthesizer, Model ABI394, using the phosphoramidite
chemistry method (Caruthers et al, 1983). For Mod-PCR mutagenesis (Chiang and Howe
1993) degeneracy was introduced into the targeted position by simultaneous delivery of
equal volumes of solution of wild-type nucleotide and an equimolar mix of all four
nucleotides resulting in a mis-incorporation rate of 0.25/nucleotide. To get a higher
frequency of specific nucleotide, especially T, degenerate oligo MUT 52 was ordered
with a higher frequency of T in all four positions. For site specific mutagenesis,
nucleotides indicated in the table were delivered at the specific positions. The sequence
of oligonucleotides used for mutagenesis, sequencing and probe preparation in this
chapter are shown in Table 3. All the oligonucleotides were diluted to a working
concentration of 100 picomoles/ul.
Targeted mutagenesis
Mutagenesis of the spacer region was specifically targeted at the four bases of the
spacer from -42 through -45 positions of Pm with respect to the transcription start site of
+1 and the effect of these mutations were studied for the contribution of the minor groove
bases in interaction with His-Mor. Three degenerate primers were designed to introduce
all possible substitutions in the spacer:
1. MUT 50: This top strand oligonucleotide was designed with NCCN in the spacer
region with degeneracy at the first and the fourth positions.
2. MUT 51: This top strand oligonucleotide was designed with GNNG in the spacer
region with middle two positions of the spacer degenerate.
3. MUT 52: This top strand oligonucleotide was designed with NNNN in the spacer
region with degeneracy at all four positions.
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Table 3: Oligonucleotides used for promoter mutagenesis.
Primer

Sequence

Comments

KRI 125

GGCGAATTCTTCTGTAAACAGTAAC
GCCGGTTAATC

KRI 126

GGCGAATTCTTCTGTAAAGAGTAAA
GCCGGTTAATC

KRI 127

GGCGAATTCTTCTGTAAGCAGTAAA
GCCGGTTAATC

KRI 128

GGCGAATTCTTCTGTACACAGTAAA
GCCGGTTAATC

KRI 129

GGCGAATTCTTCTTTAAACAGTAAA
GCCGGTTAATC

KRI 130

GGCGAATTCTTCTGTAAACATTAAC
GCCGGTTAATC

KRI 131

GGCGAATTCTTCTGTAAACAGTAAA
AAAAGTTAATC

KRI 132

GGCGAATTCTTCTGTAAACAGTAAA
TAATGTTAATC

KRI 133

GGCGAATTCTTCTGTAAACAGTAAA
CCGGGTTAATC

KRI 134

GGCGAATTCTTCTGTAAACAGTAAA
GGGGGTTAATC

KRI 135

GGCGAATTCTTCTTTAAGCAGTAAA
GCCGGTTAATC

KRI 136

GGCGAATTCTTCTGTAAACATTAAA
GCCGGTTAATC

KRI 137

GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCCTGCTTTTTTTACG

KRI 138

GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCCGTCTTTTTTTACG

Top strand mutagenic primer
designed to incorporate
mutation 1 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 5 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 8 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 10 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 14 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 17 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 18 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 19 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 20 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 21 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 23 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 26 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 9 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 11 in Pm.
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Table 3 (continued).
Primer

Sequence

Comments

KRI 139

GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCCGGATTTTTTTACG

KRI 140

GGCGAATTCTTCTGAAAACAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG

KRI 141

GGCGAATTCTTCTTTAAACAGTAAA
GCCGGTTAATCCGGCATTTTTTACG

KRI 142

GGCGAATTCTTCTGTAAACAGTAAA
GCCGTTTAATCCGGCTTTTTTTACG

KRI 143

GGCGAATTCTTCTGTAAACAGTCAA
GCCGGTGAATCCGGCTTTTTTTACG

KRI 144

GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTACTCCGGCTTTTTTTACG

KRI 145

GGCGAATTCTTCTGTAAAAAGTAAA
GCCGGTTAATTCGGCTTTTTTTACG

KRI 146

GGCGAATTCTTCTGTAAACAGTAAA
GCCGGTTAATCTGGCTTTTTTTACG

KRI 147

GGCGAATTCTTCTGTAAACATTAAA
GCCGTTTAATCCGGCTTTTTTTACG

KRI 148

GGCGAATTCTTCTTTAAGCAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG

KRI 149

GGCGAATTCTTCTTTAAACAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG

KRI 150

GGCGAATTCTTCTGTAAGCAGTAAA
GCCGGTTAATCCGGTTTTTTTTACG

KRI 151

GGCGAATTCTTCTGTAAACAGTTAA
GCCGGTAAATCCGGCTTTTTTTACG

KRI 152

GGCGAATTCTTCTGTAAACAGATTA
GCCGGAATATCCGGCTTTTTTTACG

Top strand mutagenic primer
designed to incorporate
mutation 12 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 13 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 15 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 2 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 3 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 4 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 6 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 7 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 16 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 22 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 24 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 25 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 27 in Pm.
Top strand mutagenic primer
designed to incorporate
mutation 28 in Pm.
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Table 3 (continued).
Primer

Sequence

KRI 153

GGCGAATTCTTCTGTAAACATATTCG Top strand mutagenic primer
CCGGAATATCCGGCTTTTTTTACG
designed to incorporate
mutation 29 in Pm.
GGCGAATTCTTCTGTAAACAGTAAA Top strand degenerate primer
NCCNGTTAATC
to mutagenize the last two
positions of the spacer.
GGCGAATTCTTCTGTAAACAGTAAA Top strand degenerate primer
GNNGGTTAATC
to mutagenize the middle two
positions of the spacer.
GGCGAATTCTTCTGTAAACAGTAAA Top strand degenerate primer
NNNNGTTAATC
to mutagenize all four
positions of the spacer.
GGCGAATTCTTCTGTAAACAGTAAA Top strand mutagenic primer
GGACGTTAATC
with GGAC in the spacer
region.
GGCGAATTCTTCTGTAAACAGTAAA Top strand mutagenic primer
GACGGTTAATC
with GAGC in the spacer
region.
GGCGAATTCTTCTGTAAACAGTAAA Top strand mutagenic primer
ACCCGTTAATC
with ACCC in the spacer
region.
CCTGGATCCGTACGGTTATTCATCAC Bottom strand wild-type
AG
primer to be used with all the
above primers for PCR
amplification.

MUT 50
MUT 51
MUT 52
MUT 528
MUT 529
MUT 530
MLK 7

Comments

The oligonucleotide sequences are written from the 5’ to 3’direction. The letters in red
indicate the mutations introduced. The numbers in bold red are the mutations as they
were numbered in this study.
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The rationale behind the various degenerate oligonucleotides was that if Q68 and
Y70 contacted the bases of the minor grove spacer:
1. If it made contacts with the G’s, then we would get more frequency of mutant
phenotypes with MUT 50 and MUT 52.
2. If it made contacts with the C’s then we would get more frequency of mutant
phenotypes with MUT 51 and MUT 52.
3. If all four positions were equally important for the contacts of the side chains of
the amino acids then we would get more or less equal distribution of mutant
phenotypes with all the three degenerate oligonucleotides.
A single step PCR mutagenesis was carried out with degenerate top strand
primers MUT 50, MUT 51 and MUT 52 and the bottom strand wild-type primer MLK 7
in separate reactions. This introduced a library of substitutions in the spacer region
corresponding to the various bases in the degenerate oligonucleotides. For introducing all
other mutations in Pm, primers with the specific mutations were designed as given in the
Table 3 and a single step PCR mutagenesis was carried out with these top strand primers
and the bottom strand wild-type primer MLK 7 in separate reactions. Thus, the PCR
products had incorporated the specific mutations that were designed for mutagenesis of
the various positions of Pm. The program used for amplification was as follows: 1 min at
94°C, 1 min at 50°C and 1 min at 72°C for 30 cycles followed by 5 min at 72°C in a
PTC-100 thermal cycler (MJ Research Inc., Watertown, MA). All the mutagenic
oligonucleotides had the EcoR1 site at its 5’ end preceded by 3 extra nucleotides and the
primer MLK 7 had the BamH1 site followed by additional nucleotides to facilitate
restriction digest of the insert PCR products.
The rest of the experimental protocol was similar for both the spacer region
mutagenesis and all other Pm mutations. PCR products were cleaned up using Qiaquick
PCR purification kit and then subjected to double restriction digest with EcoR1 and
BamH1 at 37°C for 4 hours. The vector pIA14 that was used for spacer region
mutagenesis and vector pIA12 that was used for all other Pm mutagenesis were also
subjected to similar restriction digests and also phosphatased with shrimp alkaline
phosphatase to prevent re-ligation of vectors cut by just one enzyme. Ligation reactions
with the digested PCR products as inserts and digested vector were incubated at 16°C
overnight for about 18-20 hours. The ligation mixture was transformed into MH13418
competent cells, which has His-Mor containing pIA69 plasmid.
Determination of plate phenotypes
Transformants were plated on MacConkey lactose agar plates with
chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) and IPTG (50 μM). The two plasmid
system was used throughout this study. The promoter plasmid, pIA14 has ampicillin
resistance and the protein plasmid, pIA69 has chloramphenicol resistance. The bacterial
cells which have both the plasmids will grow on plates with ampicillin and
chloramphenicol. The induction of His-Mor expression is through the action of IPTG
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which induces the PlacUV5 promoter in pIA69 plasmid. The His-Mor thus expressed, binds
to Pm on the pIA12 derivative, pIA14 which had the wild-type Pm or the cloned Pm with
mutations. Gene lacZ is immediately downstream of the Pm promoter and is under its
control for activity. Figure 14 illustrates the two plasmid system.
The level of activation of Pm depends on the interaction of His-Mor with the
promoter and this determines the level of expression of the lacZ gene. Normal expression
of lacZ is indicated by a red color on MacConkey plates and any defect in its expression
is observed by a different colony phenotype. Red colonies with a white halo indicate
lower than wild-type expression of lacZ. No expression of lacZ is observed as white
colonies on the plate. Red centered phenotype indicates an intermediate expression. The
expression levels of lacZ from the plate phenotyping and in vivo β-galactosidase activity
can thus be used to study interactions between His-Mor, promoter DNA and RNAP.
The phenotypic frequency of the mutant libraries was calculated based on the
distribution of different phenotypes among the candidates. Plate phenotyping was done
by observing the color of the colonies on the MacConkey lactose agar plates after
incubating the plates at 37°C for 16 hours. The fully functional mutations of Pm gave red
colonies similar to wild-type and the defective ones gave red centered or white
phenotypes depending on partially defective or fully defective phenotypes. The colors
were scored relative to those of positive control (wild-type pIA14 plasmid in
transformation) and the negative control (transformation of pIA12 which lacks Pm). A
few candidates from each phenotype were selected and purified and their promoter
plasmids, pIA14 were sequenced to identify the mutations.
Preparation of competent cells
Competent cells were prepared by CaCl2 method (Mandel and Higa, 1970):
1. MH13418, which has the protein His-Mor plasmid pIA69, was streaked on LB
agar plate with chloramphenicol (25 μg/ml) and was incubated overnight at 37˚C.
2. Single colony was inoculated into 5 ml plain LB and grown overnight at 37˚C
shaker.
3. Next morning, the seed culture was inoculated into 100 ml plain LB w/o
antibiotics and grown in 37˚C shaker till the OD reached 0.4-0.6 (for about 3 hrs).
4. Flasks were kept on ice for 15 min.
5. 25 ml of the culture was taken in each of the 30 ml Corex tubes and centrifuged at
10000 rpm for 15 min (SS34 rotor) and the supernatant was discarded.
6. 12.5 ml (50% of culture volume) sterile 0.1 M CaCl2 was taken in each tube and
left for 15 min. on ice and then resuspended.
7. It was centrifuged at 10000 rpm for 15 min (SS34 rotor) and the supernatant was
discarded. The pellet was resuspended in 2.5 ml CaCl2 and 375 µl glycerol.
8. Resuspended cells were left in cold room for 2 hrs to overnight, distributed into
200 μl aliquots, flash-frozen and stored at -80˚C freezer.
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Figure 14: The two plasmid system used to study interactions of Pm with His-Mor.
Modified with permission from Nucleic Acids Research. Artsimovitch I, Howe M.
Transcription activation by the bacteriophage Mu Mor protein: analysis of promoter
mutations in Pm identifies a new region required for promoter function. Nucl. Acids Res.
1996, 24(3): 450-7.
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Transformation protocol
The MH13418 competent cells were thawed on ice for 30 min. The ligation mix
was then added into the competent cells tube and left standing for 30 min on ice. Heat
shock treatment was given for exactly 2 min at 42˚C and then the tubes were placed
immediately on ice for 10 min. The entire volume of cells was grown on 2 ml LB broth
for 2 hrs on 37˚C shaker. 150 µl of the outgrowth transformants was plated on
MacConkey lactose agar plates with chloramphenicol (25 μg/ml), ampicillin (40 μg/ml)
and IPTG (50 μM) for plate phenotyping and selection of the clones.
Plasmid purification protocol
Wizard Plus Midiprep DNA Purification kit from Promega Corporation was used
for the extraction of the plasmids pIA14 from MH13435 and pIA12 from MH13315.
1. The strain was streaked on LB agar plates with ampicillin (40 μg/ml) and left
overnight in 37˚C incubator.
2. A single colony was inoculated into 100 ml LB broth with ampicillin (40 μg/ml)
and grown overnight in 37˚C shaker.
3. Cells were pelleted at 8000 rpm for 18 min at 4˚C.
4. The pellet was resuspended in 3 ml cell resuspension solution provided in the kit.
5. The cells were lysed in 3ml cell lysis solution provided in the kit.
6. The reaction was neutralized using 3 ml neutralization Solution from the kit.
7. It was then centrifuged at 12000 rpm for 15 min at 4˚C.
8. The supernatant was mixed with the resuspended resin and allowed to pass
through the midiprep column from the kit in a vacuum manifold.
9. After all the liquid passed through the column, it was washed twice with 15 ml
column wash solution.
10. The plasmid from the column was extracted with 300 µl preheated milliQ water
by centrifugation for 20 sec at 10000 rpm.
The plasmid preparation thus obtained was further purified with ethaonol
precipitation for further purity as follows:
1. 30 µl sodium acetate and 750 µl absolute ethanol was added to the 300 µl plasmid
preparation and kept standing at -80˚C for about 40 min.
2. The DNA was centrifuged at 10000 rpm for 10 min and the supernatant was
discarded.
3. The DNA pellet was washed twice in 1ml of 70% ethanol.
4. The pellet was then dried in vacuum for 10 min and then resuspended in 150 µl
milliQ water at pH 8.0.
The purified DNA was observed on a 1% agarose gel and quantitated on the
Thermo Scientific NanoDropTM 1000 Spectrophotometer.
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Sequencing of the plasmids
All the plasmids were sequenced using MUT 49 as the bottom strand sequencing
primer at the Molecular Resource Center (MRC) facility at the University of Tennessee
Health Science Center, Memphis. At the MRC, automated DNA sequencing was
accomplished with ABI Model 3130XL Genetic Analyzers that use four-color
fluorescence-based sequencing based on the Sanger method. Plasmid or PCR produced
DNAs were used as suitable substrates for the sequencing protocol. Samples were
submitted as template/primer mixes, with the ratio of DNA/primer dependent on the type
of template employed. Following the incorporation of the labeled ddNTPs in the
extension products, the reactions were purified by gel filtration, dried down, re-suspended
in formamide, and run on the analyzer. DNA sequencing reactions were purified with the
BigDye® XTerminator™ Purification Kit result in high signal strength when analyzed on a
DNA sequencer. Data were uploaded on the MRC server as either ab.1 files that could be
opened with ABI software or programs such as FinchTv or text files. Electropherograms,
which are the graphic colored printouts of the sequencing, were used to read the
sequences. A BLAST was performed for each of the sequences with “bl2seq” from the
NCBI site, using the sequence from wild-type promoter and the two sequences were
aligned and the base-pair mismatches were observed to check the incorporation of the
specific mutations designed.
Small scale purification of His-Mor
Overnight cultures (2 ml) of MH13355 protein expression strain with freshly
transformed His-Mor plasmid were transferred to 100 ml of LB supplemented with 25
μg/ml of chloramphenicol. The cells were grown at 37˚C until the A600 reached 0.4 - 0.6,
and then His-Mor over-expression was induced with 1 mM IPTG for 3 hrs. After
harvesting by centrifugation at 8000 rpm for 15 min at 4˚C, the cell pellets were
resuspended in 4 ml of Resuspension Buffer M containing 20 mM Tris-HCl pH 7.9, 200
mM NaCl, 0.5 mM phenylmethylsulfonylfluoride, 10% glycerol, 1 mM 2mercaptoethanol and lysed by sonication (output 40 cycles 4 for 4 minutes). After
centrifugation, the supernatants were loaded into TALON spin columns (now
equilibrated thrice with Buffer M) and washed sequentially once with 1 ml of BufferM
containing 0.1% IGEPAL CA-630 detergent, once with 1 ml of Buffer M containing 500
mM NaCl and once with 1 ml of Buffer M containing 40 mM imidazole. Proteins were
eluted four times, 0.25 ml/time, with Buffer M containing 100 mM imidazole. The final
two elutions were pooled together. The second elution and the pooled fractions were
dialysed overnight at 4˚C in a 10-kDa cutoff Slide-A-lyzer dialysis cassette in the dialysis
buffer solution (20 mM Tris-HCl pH 7.9, 50 mM NaCl, 10% glycerol, 1 mM EDTA, and
1 mM DTT). It was then supplemented with glycerol to a final concentration of 15%,
aliquoted and stored at -80˚C. Purity of the preparations was assayed on a 12.5% SDS
polyacrylamide gel stained with silver nitrate, and the protein concentration was
determined by a Bradford assay with IgG as the standard (Bradford, 1976).
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In vivo transactivation assay
Cells were grown overnight in 2 ml of M9CA medium [M9 media (20% 5X M9
salts, 20 mM glucose, 2 mM MgSO4, 0.1 mM CaCl2, 10 μg/ml each of thiamine and
Biotin) + 0.2% casamino acid] supplemented with 25-30 μg/ml chloramphenicol and 40
μg/ml ampicillin. The overnight culture was diluted 1:50 into 10 ml of fresh M9CA
medium with antibiotics and grown at 37˚C until the A600 reached 0.4 - 0.6. A 1-ml
sample was removed to serve as an uninduced control, and the remaining culture was
induced with 2 mM IPTG for 60 min. Based on the plate phenotype of individual
mutants, dilutions of the cells were made using M9CA medium, and the cells were
permeabilized by mixing with 10 μl of chloroform and 25 μl of 0.1% SDS. After
incubation for 20 min on ice, 0.5 ml of ONPG (4 mg/ml to a final concentration of 0.8
μg/μl) in Buffer Z (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4 and
50 mM 2-mercaptoethanol) was added, and the mixture was incubated at 28˚C for 20
min. The reactions were stopped by adding 250 μl of 1 M Na2CO3 and spectrophotometer
readings were taken at 420 nm for the enzymatic reaction and 600 nm for cell density.
The β-galactosidase activities were calculated according to Miller’s formula (Miller,
1972) and normalized relative to that of a wild-type culture assayed in parallel and set to
1000.
Gel mobility shift assay
The list of oligonucleotides used for gel shifts is given in Table 4. All the bottom
strand oligonucleotides were radioactively labeled. Labeled probes were prepared using
γ-P32 labeled bottom strand primer in a 10 μl labeling reaction with 1 μl T4
polynucleotide kinase, 4 μl milliQ water, 1 μl kinase buffer and 3 μl γ-P32 ATP (500
μCurie stock from Perkin Elmer) and incubated at 37˚C for 60 min and then at 95˚C for 2
min to inactivate the enzyme. Then, 1.1 μl of 0.5 M NaCl (final concentration of 50 mM),
and 5 μl of the top strand oligo was added to the reaction mix, kept on a 100˚C heat block
and the block was disconnected for the oligonucleotides to anneal gradually as the
temperature drops from 100˚C to room temperature. After it drops to room temperature,
35 μl binding buffer (20 mM Tris-HCl pH 7.9, 50 mM NaCl, 5% glycerol and 1 mM
DTT) was added and the double stranded radioactively labeled oligonucleotides were
purified using G25 (for oligonucleotides from 10-20 bases in length) and G50 (for
oligonucleotides 20-50 bases in length) columns from GE Healthcare.
A 20 μl reaction volume containing probe (about 30 radioactive counts per second
as measured with a Geiger counter), 50 ng of calf-thymus DNA, and different
concentrations of His-Mor protein in binding buffer (20 mM Tris-HCl pH 7.9, 50 mM
NaCl, 5% glycerol and 1 mM DTT) was incubated at room temperature for 20 minutes.
Two different amounts (400 ng and 800 ng) of wild-type His-Mor were used with each of
the labeled probes in most cases while in some cases three amounts (200 ng, 400 ng and
800 ng) of protein was used. There was one tube with a negative control without His-Mor
and with the probe alone. One positive control was used for every gel which had the
wild-type promoter Pm labeled probe with wild-type His-Mor.
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Table 4: List of oligonucleotides for gel shifts.
Oligo
numbers
KRI 57
KRI 58
KRI 59
KRI 60
MUT 18
MUT 19
KRI 49
KRI 50
KRI 51
KRI 52
KRI 53
KRI 54
KRI 55
KRI 56
KRI 61
KRI 62
KRI 63
KRI 64

Sequence

Comments

CAGTAAAGCCGGTTAATC

Top strand 18-mer
oligo probe.
GATTAACCGGCTTTACTG
Bottom strand 18-mer
oligo probe.
ACAGTAAAGCCGGTTAATCC
Top strand 20-mer
oligo probe.
GGATTAACCGGCTTTACTGT
Bottom strand 20-mer
oligo probe.
AACAGTAAAGCCGGTTAATCCG
Top strand 22-mer
oligo probe.
CGGATTAACCGGCTTTACTGTT
Bottom strand 22-mer
oligo probe
AAACAGTAAAGCCGGTTAATCCGG
Top strand 24-mer
oligo probe.
CCGGATTAACCGGCTTTACTGTTT
Bottom strand 24-mer
oligo probe.
TAAACAGTAAAGCCGGTTAATCCGGC
Top strand 26-mer
oligo probe.
GCCGGATTAACCGGCTTTACTGTTTA
Bottom strand 26-mer
oligo probe.
GTAAACAGTAAAGCCGGTTAATCCGGCT
Top strand 28-mer
oligo probe.
AGCCGGATTAACCGGCTTTACTGTTTAC
Bottom strand 28-mer
oligo probe.
TGTAAACAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe.
AAGCCGGATTAACCGGCTTTACTGTTTACA Bottom strand 30-mer
oligo probe.
TGTAAACAGTAACGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 1 in Pm.
AAGCCGGATTAACCGGCGTTACTGTTTACA Bottom strand 30-mer
oligo probe with
mutation 1 in Pm.
TGTAAACAGTAAAGCCGTTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 2 in Pm.
AAGCCGGATTAAACGGCTTTACTGTTTACA Bottom strand 30-mer
oligo probe
containing mutation 2
in Pm.
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Table 4 (continued).
Oligo
numbers
KRI 65
KRI 66
KRI 67
KRI 68
KRI 69
KRI 70
KRI 71
KRI 72
KRI 73
KRI 74
KRI 75
KRI 76
KRI 77

Sequence

Comments

TGTAAACAGTCAAGCCGGTGAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 3 in Pm.
AAGCCGGATTCACCGGCTTGACTGTTTACA Bottom strand 30mer oligo probe with
mutation 3 in Pm.
TGTAAACAGTAAAGCCGGTTACTCCGGCTT Top strand 30-mer
oligo probe with
mutation 4 in Pm.
AAGCCGGAGTAACCGGCTTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 4 in Pm.
TGTAAAGAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 5 in Pm.
AAGCCGGATTAACCGGCTTTACTCTTTACA Bottom strand 30mer oligo probe with
mutation 5 in Pm.
TGTAAAAAGTAAAGCCGGTTAATTCGGCTT Top strand 30-mer
oligo probe with
mutation 6 in Pm.
AAGCCGAATTAACCGGCTTTACTTTTTACA Bottom strand 30mer oligo probe with
mutation 6 in Pm.
TGTAAACAGTAAAGCCGGTTAATCTGGCTT Top strand 30-mer
oligo probe with
mutation 7 in Pm.
AAGCCAGATTAACCGGCTTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 7 in Pm.
TGTAAGCAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 8 in Pm.
AAGCCGGATTAACCGGCTTTACTGCTTACA Bottom strand 30mer oligo probe with
mutation 8 in Pm.
TGTAAACAGTAAAGCCGGTTAATCCTGCTT Top strand 30-mer
oligo probe with
mutation 9 in Pm.
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Table 4 (continued).
Oligo
numbers
KRI 78
KRI 79
KRI 80
KRI 81
KRI 82
KRI 83
KRI 84
KRI 85
KRI 86
KRI 87
KRI 88
KRI 89
KRI 90
KRI 91

Sequence

Comments

AAGCAGGATTAACCGGCTTTACTGTTTACA

Bottom strand 30mer oligo probe with
mutation 9 in Pm.
TGTACACAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 10 in Pm.
AAGCCGGATTAACCGGCTTTACTGTGTACA Bottom strand 30mer oligo probe with
mutation 10 in Pm.
TGTAAACAGTAAAGCCGGTTAATCCGTCTT Top strand 30-mer
oligo probe with
mutation 11 in Pm.
AAGACGGATTAACCGGCTTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 11 in Pm.
TGTAAACAGTAAAGCCGGTTAATCCGGATT Top strand 30-mer
oligo probe with
mutation 12 in Pm.
AATCCGGATTAACCGGCTTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 12 in Pm.
TGAAAACAGTAAAGCCGGTTAATCCGGTTT Top strand 30-mer
oligo probe with
mutation 13 in Pm.
AAACCGGATTAACCGGCTTTACTGTTTTCA Bottom strand 30mer oligo probe with
mutation 13 in Pm.
TTTAAACAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 14 in Pm.
AAGCCGGATTAACCGGCTTTACTGTTTAAA Bottom strand 30mer oligo probe with
mutation 14 in Pm.
TTTAAACAGTAAAGCCGGTTAATCCGGCAT Top strand 30-mer
oligo probe with
mutation 15 in Pm.
ATGCCGGATTAACCGGCTTTACTGTTTAAA Bottom strand 30mer oligo probe with
mutation 15 in Pm.
TGTAAACATTAAAGCCGTTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 16 in Pm.
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Table 4 (continued).
Oligo
numbers
KRI 92
KRI 93
KRI 94
KRI 95
KRI 96
KRI 97
KRI 98
KRI 99
KRI 100
KRI 101
KRI 102
KRI 103
KRI 104
KRI 105

Sequence

Comments

AAGCCGGATTAAACGGCTTTAATGTTTACA

Bottom strand 30mer oligo probe with
mutation 16 in Pm.
TGTAAACATTAACGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 17 in Pm.
AAGCCGGATTAACCGGCGTTAATGTTTACA Bottom strand 30mer oligo probe with
mutation 17 in Pm.
TGTAAACAGTAAAAAAAGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 18 in Pm.
AAGCCGGATTAACTTTTTTTACTGTTTACA
Bottom strand 30mer oligo probe with
mutation 18 in Pm.
TGTAAACAGTAAATAATGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 19 in Pm.
AAGCCGGATTAACATTATTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 19 in Pm.
TGTAAACAGTAAACCGGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 20 in Pm.
AAGCCGGATTAACCCGGTTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 20 in Pm.
TGTAAACAGTAAAGGGGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 21 in Pm.
AAGCCGGATTAACCCCCTTTACTGTTTACA Bottom strand 30mer oligo probe with
mutation 21 in Pm.
TTTAAGCAGTAAAGCCGGTTAATCCGGTTT Top strand 30-mer
oligo probe with
mutation 22 in Pm.
AAACCGGATTAACCGGCTTTACTGCTTAAA Bottom strand 30mer oligo probe with
mutation 22 in Pm.
TTTAAGCAGTAAAGCCGGTTAATCCGGCTT Top strand 30-mer
oligo probe with
mutation 23 in Pm.
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Table 4 (continued).
Oligo
numbers
KRI 106

Sequence

Comments

AAGCCGGATTAACCGGCTTTACTGCTTAAA

KRI 107

TTTAAACAGTAAAGCCGGTTAATCCGGTTT

KRI 108

AAACCGGATTAACCGGCTTTACTGTTTAAA

KRI 109

TGTAAGCAGTAAAGCCGGTTAATCCGGTTT

KRI 110

AAACCGGATTAACCGGCTTTACTGCTTACA

KRI 111

TGTAAACATTAAAGCCGGTTAATCCGGCTT

KRI 112

AAGCCGGATTAACCGGCTTTAATGTTTACA

KRI 113

TGTAAACAGTTAAGCCGGTAAATCCGGCTT

KRI 114

AAGCCGGATTTACCGGCTTAACTGTTTACA

KRI 115

TGTAAACAGATTAGCCGGAATATCCGGCTT

KRI 116

AAGCCGGATATTCCGGCTAATCTGTTTACA

KRI 117

TGTAAACATATTCGCCGGAATATCCGGCTT

KRI 118

AAGCCGGATATTCCGGCGAATATGTTTACA

KRI 119

ATTAACGCCGGTTAAT

Bottom strand 30mer oligo probe with
mutation 23 in Pm.
Top strand 30-mer
oligo probe with
mutation 24 in Pm.
Bottom strand 30mer oligo probe with
mutation 24 in Pm.
Top strand 30-mer
oligo probe with
mutation 25 in Pm.
Bottom strand 30mer oligo probe with
mutation 25 in Pm.
Top strand 30-mer
oligo probe with
mutation 26 in Pm.
Bottom strand 30mer oligo probe with
mutation 26 in Pm.
Top strand 30-mer
oligo probe with
mutation 27 in Pm.
Bottom strand 30mer oligo probe with
mutation 27 in Pm.
Top strand 30-mer
oligo probe with
mutation 28 in Pm.
Bottom strand 30mer oligo probe with
mutation 28 in Pm.
Top strand 30-mer
oligo probe with
mutation 29 in Pm.
Bottom strand 30mer oligo probe with
mutation 29 in Pm.
Top strand 16-mer
oligo with mutation
17 in Pm.
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Table 4 (continued).
Oligo
numbers
KRI 120

Sequence

Comments

ATTAACCGGCGTTAAT

KRI 121

CATTAACGCCGGTTAATC

KRI 122

GATTAACCGGCGTTAATG

KRI 123

ACATTAACGCCGGTTAATCC

KRI 124

GGATTAACCGGCGTTAATGT

Bottom strand 16mer oligo with
mutation 17 in Pm.
Top strand 18-mer
oligo with mutation
17 in Pm.
Bottom strand 18mer oligo with
mutation 17 in Pm.
Top strand 20-mer
oligo with mutation
17 in Pm.
Bottom strand 20mer oligo with
mutation 17 in Pm.
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The reaction mixture subjected to electrophoresis on a 10% non-denaturing,
native acrylamide gel (19.5 ml milliQ water, 3 ml of 5X TBE buffer, 7.5 ml of 40% 29:1
acrylamide/bis-acrylamide solution, 150 μl of 10% ammonium persulfate and 30 μl
TEMED solution) and run in 0.5 X TBE buffer at 260 V for 90min at 4°C. Initial
exposure of the gels to X-OMAT BioMax-MR film was done without drying for 6-18
hours as indicated at -80˚C. The exposed films were then developed and observed for
His-Mor binding to the labeled probes. Quantitative assays for the His-Mor binding was
done in a phosphoimager using the Image Quant software which gave the percentage of
the probe bound by wild-type His-Mor for each of the probes.
Results
Spacer region mutagenesis and phenotypic frequency
For the spacer region, degenerate oligonucleotides were used to introduce all
possible substitutions in the positions -42 through -45. The 3 primers that were designed
for the purpose were:
1. MUT 50 with NCCN in the spacer region with degeneracy at the first and the
fourth positions.
2. MUT 51 with GNNG in the spacer region with degeneracy at the middle two
positions.
3. MUT 52 with NNNN in the spacer region with degeneracy at all four positions.
The initial analysis showed a very low incorporation of T in the oligonucleotides,
so we ordered another primer MUT 520 with NNNN in the spacer region with a higher
percentage of incorporation of T in all the four positions. The degenerate primers were
designed for Mod-PCR (Chiang and Howe, 1993) in a way to change the targeted region
by mutating the targeted bases to a random nucleotide using a 0.25 incorporation rate for
each base A/T/G/C so that we got a library of substitutions in the region.
The mutagenesis was performed in PCR reactions using one degenerate primer as
the top strand primer and a wild-type primer, MLK 7 as the bottom strand primer. All the
mutagenic oligonucleotides were designed in such a way that they had the EcoRI site at
its 5’ end preceded by 3 extra nucleotides and the primer MLK 7 was designed with the
BamHI site at its 5’ end followed by additional nucleotides to facilitate restriction digest.
The resulting PCR products were digested with EcoRI and BamHI and cloned into a
similarly digested vector, pIA14 such that the Pm region of pIA14 was removed and
replaced with this library of mutations. The ligation mixture was transformed into
MH13418 containing the plasmid pIA69 with the wild-type His-Mor gene inducible by
IPTG. The vector itself is the reported plasmid with the Pm-lacZ fusion. The activities of
mutant promoters were examined by the color development of the transformants on
MacConkey lactose plates with chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) and
IPTG (50 μM).
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The frequency of phenotypes in a mutant library was used as a preliminary
indicator of the functional relevance of the bases in the spacer region. Mutant library with
MUT 50 gave 13.2% white colonies indicating defective phenotypes. Mutant library with
MUT 51 gave 11.2% white colonies, while the library with MUT 52 gave 9.8% whites.
This initial analysis of the percentage of defective phenotypes was used as an indication
as to the importance of the bases of the minor groove. Since just about 10% of colonies
gave mutant phenotypes, it could be concluded that the minor groove spacer region can
tolerate mutations and that interactions in the minor groove may not be base-specific. An
equal proportion of red and white colonies were chosen for sequencing of the plasmids to
determine the mutations incorporated in those positions.
The 62 unique red sequences that were isolated are given in the Table 5 along
with their corresponding β-gal values. Three unique sequences (GGAC, GACG and
ACCC) were identified which conferred defective phenotypes. All other sequences which
gave us defective phenotypes had mutations elsewhere in the plasmid, so they were not
used for further analysis. To re-check the three mutations which gave defective
phenotypes, these specific primers mutations were introduced in the spacer region. This
time, majority of the clones had the wild-type phenotype even though they contained the
specific mutations that previously gave defective phenotypes. This could be attributed to
mutations elsewhere in the plasmid which gave defective phenotypes in the original
cloning.
Extensive mutagenesis of Pm
In order to optimize Mor binding at Pm, extensive targeted mutagenesis was
performed for the positions of Pm from -30 through -57 and specific mutations were
introduced into those positions as given in Table 1. In addition to this, four specific
mutations were also introduced in the 4-bp spacer region that was used as a subset of the
spacer region mutants for analysis of in vivo transcription activation assays and gel shifts.
Primers KRI 125 through KRI 153 were used for this purpose. The mutagenesis was
performed in PCR reactions using one mutagenised primer as the top strand primer and a
wild-type primer, MLK 7 as the bottom strand primer. All the mutagenic oligonucleotides
were designed in such a way that they had an EcoRI site at its 5’ end preceded by 3 extra
nucleotides and the primer MLK 7 was designed with the BamHI site at its 5’ end, again
followed by additional nucleotides to facilitate restriction digestion of the PCR products
with the two oligonucleotides. The resulting PCR products were digested with EcoRI and
BamHI and cloned into a similarly digested vector, pIA12 such that the Pm region had
incorporated the mutations designed for the specific positions. The ligation mixture was
transformed into MH13418 containing the plasmid pIA69 with the wild-type his-mor
gene inducible by IPTG. The vector itself is the reporter plasmid with the Pm-lacZ fusion.
The activities of mutant promoters were examined by color development of the
transformants on MacConkey lactose plates containing half the amount of lactose and
also chloramphenicol (25 μg/ml), ampicillin (40 μg/ml) and IPTG (50 μM).
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Table 5: Mutations of the spacer region which gave red colonies.
-45
G
G
A
A
G
G
G
G
G
G
G
C
T
A
A
G
G
C
G
A
C
C
G
G
C
C
C
G
C
A
G
G
A
A
G
T
T
A
G
T
C
T

-44
C
C
C
C
C
G
A
A
G
G
A
A
C
G
A
A
G
G
C
C
A
G
G
A
A
C
C
A
C
A
T
C
G
A
T
T
T
G
T
T
C
G

-43
C
C
C
C
C
G
C
A
C
A
G
A
G
C
A
G
C
A
A
G
A
G
G
G
G
G
G
T
C
G
A
G
A
T
A
T
A
C
T
T
T
T
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-42
G
A
A
G
C
G
G
G
G
G
G
A
G
G
G
A
C
G
G
G
C
C
A
C
G
C
G
G
A
G
G
A
A
G
T
G
A
T
T
T
A
T

β-GAL
VALUES
784
1310
1189
1251
1058
689
946
1014
1360
729
1122
290
993
445
588
708
1222
637
1227
640
1223
964
772
945
574
485
547
516
713
850
439
864
1304
352
833
392
1264
888
410
664
574

Table 5 (continued).
-45
G
A
C
T
A
T
A
G
C
C
G
C
T
G
T
G
C
A
A
C
T
A
A

-44
C
T
T
A
T
T
A
T
G
C
C
A
G
C
G
A
T
C
C
T
C
A
A

-43
C
T
T
G
T
C
T
T
T
C
T
T
G
C
C
C
T
T
C
C
A
G
A

-42
G
T
A
T
A
G
T
G
C
T
T
T
T
C
G
T
T
C
C
T
G
A
A

β-GAL
VALUES
293
1149
480
902
927
729
745
849
934
551
433
580
1022
913
1077
549
756
917
728
323
549
579

The positions of the bases are given at the top of each column with respect to the
transcription start site of +1. Immediately following that, in the first row in red are the
wild-type bases at each of those positions. The β-gal values are the readings from one
experimental assay and are given with respect to the wild-type set to 1000 and the
negative control calculated to be 2.
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Observation of phenotypes
The phenotypes of the transformants were observed after incubation of the plates
at 37°C for 16 hours. The colonies were scored relative to the wild-type strain MH20655
(positive control) which was red in color and the strain MH20656 (negative control)
which had the vector plasmid pIA12, without Pm and was white on the MacConkey
plates. The phenotypes were as given in Table 6. There were red colonies, reds with a
white halo around them and white colonies as a result of the different mutations. The red
colonies indicated those with wild-type promoter activity. The red ones with a small
white halo indicated a slightly reduced activity as compared with wild-type and colonies
which were red with a large white halo indicated an even more reduced activity. White
colonies indicated a defective phenotype similar to the negative control with almost no
detectable promoter activity.
In vivo transactivation assay
After one hour of Mor expression from the PlacUV5 promoter, the ability of Mor to
activate transcription from Pm with the different mutations was assayed by measuring βgalactosidase activity. They were done in parallel with a wild-type control. They are
discussed with the results of the gel shifts as the effect of each mutation is discussed. The
β-gal values are an average of two assays and are relative to the wild-type activity from
wild-type Pm set to 1000.
Gel retardation assay results
Gel retardation assays were performed to test the ability of His-Mor to bind to the
promoters with specific mutations. They were done at two concentrations of wild-type
His-mor, 200 ng and 400 ng to determine the shift caused by the lowest concentration of
the protein. Each gel had a control with 30-mer oligonucleotide which had the wild-type
promoter and the intensity of the shift by the mutagenised oligonucleotides was scored
relative to the control set to 100. The effects of gel shifts due to the mutations are
discussed as a percentage of the wild-type in most cases except in cases where there was
no detectable shift to assign a percent value to it. The results of the gel shift in correlation
with the plate phenotypes and in vivo β-galactosidase activity levels are discussed on the
following pages from Figure 15 through Figure 26. They are arranged as per the sequence
of the mutations and the gels.
Both the in vivo transactivation assay values and gel retardation assay results are
discussed with each mutation and also in the summarized results and discussion section.
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Table 6: Phenotypes of strains with specific promoter mutations.
Mutation

Mutation alterations

Strain

Colony phenotype

1

-46 A to C

MH20561

2

-41 G to T

MH20616

3

MH20620

4

-48 A to C and
-39 T to G
-37 A to C

Red with small white
halo
Red with small white
halo
White

MH20624

Red

5

-52 C to G

MH20564

6

MH20627

7

-52 C to A and
-35 C to T
-34 C to T

Red with small white
halo
Red

MH20630

Red

8

-53 A to G

MH20567

9

-33 G to T

MH20600

Red with small white
halo
Red

10

-54 A to C

MH20570

11

-32 G to T

MH20603

Red with larger white
halo than others
Red

12

-31 C to A

MH20607

Red

13

-56 T to A and
-31 C to T
-57 G to T

MH20610

Red

MH20575

Red with small white
halo
Red with small white
halo
Red with small white
halo
Red with small white
halo
Red with small white
halo
Red with large white
halo, almost red centered
Red with small white
halo

14
15
16
17
18
19
20

-57 G to T and
-30 T to A
-50 G to T and
-41 G to T
-50 G to T and
-46 A to C
-42 through -45
AAAA
-42 through -45
TAAT
-42 through -45
GGCC

MH 20614
MH20631
MH20576
MH20584
MH20587
MH20590
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Table 6 (continued).
Mutation

Mutation alterations

Strain

Colony phenotype

21

-42 through -45
GGGG
-57 G to T, -53 A to G
and -31 C to T
-57 G to T and -53 A
to G
-57 G to T and -31 C
to T
-53 A to G and -31 C
to T
-50 G to T

MH20591

Red

MH20635

Red

MH20594

Red

MH20638

Red

MH20641

Red

MH20597

Red

-48 A to T and -39 T
to A
-49 to -47 ATT and
-40 to -38 AAT
-50 to -46 TATTC
and -40 to -38 AAT
Wild-type Pm

MH20644

White

MH20646

White

MH20651

White

MH20655

Red

Without Pm

MH20656

White

22
23
24
25
26
27
28
29
Positive
Control
Negative
control
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Figure 15. Gel shift for mutations 1, 2 and 3
Mutation 1 (-46 A to C): This mutation led to red colonies with a small white halo around
them indicating somewhat lower activity, which correlated with a β-galactosidase activity
of 518 relative to the wild-type activity set to 1000. The gel shift for this mutation
revealed a slightly higher binding as compared to that of the wild-type at both
concentrations of His-Mor (400 and 800 ng). Thus, changing this A to a C is tolerated by
the promoter without drastically changing its activity.
Mutation 2 (-41 G to T): This mutation gave red colonies with a small white halo around
them indicating lower activity which correlated with its β-galactosidase activity of 377
relative to the wild-type activity set to 1000. The gel retardation assay with this mutation
showed significantly lower binding as compared to the wild-type at both the
concentrations of His-Mor (400 and 800 ng). This weak binding to the promoter DNA
would explain its lower capacity to activate transcription from the promoter, as indicated
by its lower β-galactosidase activity. This indicates that the G in this position is important
for Mor binding.
Mutation 3 (-48 A to C and -39 T to G): This mutation gave white colonies on
MacConkey plates, indicating a severely defective phenotype similar to the negative
control with a deleted promoter Pm. Mor failed to bind to the promoter DNA as seen from
the gel shift data at levels even as high as 800 ng of protein, and this explained its almost
undetectable β-galactosidase activity of 0.3. As wild-type His-Mor failed to bind to the
promoter with this mutation, it could not activate transcription from that promoter as it
could not recruit RNA polymerase to the promoter.
These specific bases seem to be critical for the promoter binding and transactivation
function of His-Mor. It also indicates that the specific bases are important for Mor
recognition and binding rather than just symmetry because even thought this mutation
maintained the symmetry with a G/C combination as opposed to the wild-type of A/T
combination, yet it failed to bind His-Mor.
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Figure 16: Gel shift for mutations 4, 5 and 6.
Mutation 4 (-37 A to C): This mutant exhibited a red phenotype on MacConkey plates,
indicating a wild-type phenotype and functionally active promoter. This was further
justified by its His-Mor binding which was similar to the wild-type promoter at both
concentrations of His-Mor (400 and 800 ng), and its in vivo β-galactosidase activity of
951, that was very close to the wild-type promoter activity. Even though a symmetrical
change was made at this position with respect to -50G centered at -43.5, it did not
increase the binding of His-Mor. Thus, symmetry at this position may not contribute
significantly to Mor binding and activation, as it tolerates both C and A at this position
without much effect.
Mutation 5 (-52 C to G): This mutation imparted a red phenotype with a small white halo
around the colonies indicating a slightly lower promoter activity which correlated with its
β-galactosidase activity of 639 relative to the wild-type activity set to 1000. The gel
retardation assay indicated that the promoter with this mutation had the capacity to bind
wild-type His-Mor to about 80% of the wild-type promoter at both concentrations of
His-Mor (400 and 800 ng). This position lies just outside the Mor-binding region as
indicated in footprinting analysis (Kahmeyer-Gabbe and Howe, 1996). Making this
position symmetrical with respect to -35C centered at -43.5 reduced its capacity to bind
His-Mor and gave a lower promoter activity as compared to wild-type. This indicates the
contribution of this position to Mor binding and promoter activity.
Mutation 6 (-52 C to A and -35 C to T): This double mutation imparted a red phenotype
with a small white halo around the colonies similar to that of mutation 5, indicating a
slightly lower promoter activity, which correlated with its β-galactosidase activity of 597
relative to the wild-type activity set to 1000. The gel retardation assay showed that the
promoter with this double mutation had the capacity to bind wild-type His-Mor to about
70% of the wild-type promoter, which explains its lower level of in vivo promoter
activity as measured in the β-galactosidase assay. This mutation and mutation 5, both
indicate the specific contribution of -52C to Mor binding and promoter activity. Also, it is
not the symmetry at these positions that is important for Mor binding but the presence of
the specific bases -52C and -35C that stabilize Mor binding to Pm.
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Figure 17: Gel shift for mutations 7, 8 and 9.
Mutation 7 (-34 C to T): This mutant exhibited a red (wild-type) phenotype on
MacConkey plates indicating a functionally active promoter. This conclusion was further
supported by its binding to His-Mor and its in vivo β-galactosidase activity of 809, both
of which were similar to those of wild-type promoter. Even though a symmetrical change
was made at this position with respect to -53A centered at -43.5, it did not increase the
binding of His-Mor. Thus, symmetry at this position may not contribute significantly to
Mor binding and activation as it tolerates both C and T at this position without much
effect. This position lies just outside the Mor-binding region of Pm and as expected, it
does not significantly contribute to Mor binding. The β-galactosidase activity indicated
that the nucleotide at this position is also not very important for RNA polymerase binding
and that it can tolerate base changes.
Mutation 8 (-53 A to G): This mutation imparted a red phenotype with a small white halo
around the colonies similar to that of mutation 5, indicating a slightly lower promoter
activity which correlated with its β-galactosidase activity of 630 relative to the wild-type
activity set to 1000. The gel retardation assay indicated that the promoter with this
mutation had the capacity to bind wild-type His-Mor to about 80% of the wild-type
promoter which correlates with its lower level of in vivo promoter activity as measured in
the β-galactosidase assay. This mutation also introduced a symmetrical substitution
similar to mutation 7, but with a G/C combination as opposed to the A/T combination
that was introduced by mutation 7 at these positions. Even though a promoter with this
mutation binds His-Mor almost as effectively as wild-type, this position probably
contributes to transactivation through interaction with RNA polymerase. As noted earlier,
this position lies in the region predicted to interact with one of the α-CTD subunits of the
RNAP (Ma and Howe, 2004). This would explain why a mutation at this position bound
the protein but displayed a lower in vivo activity.
Mutation 9 (-33 G to T): This mutation imparted a red phenotype with a small white halo
around each colony similar to that of mutation 8, indicating a slightly lower promoter
activity which correlated with its β-galactosidase activity of 654. The gel retardation
assay indicated that the promoter with this mutation had the capacity to bind wild-type
His-Mor to about 80% of the wild-type promoter which explains its lower level of in vivo
promoter activity as measured in the β-galactosidase assay. This mutation introduces a
symmetrical change at this position with respect to -54A. The closer-to-wild-type binding
by His-Mor but significantly lower in vivo activity indicates that even though it lies
beyond the Mor-binding site, -33G contributes to the activation of the promoter probably
through its interaction with RNAP.
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Figure 18: Gel shift for mutations 10, 11 and 12.
Mutation 10 (-54 A to C): This mutation imparted a red phenotype with a larger white
halo around the colonies similar to mutation 8, indicating a lower promoter activity which
correlated with its β-galactosidase activity of 335. The gel retardation assay indicated that
the promoter with this mutation had the capacity to bind wild-type His-Mor to about 85%
of the wild-type promoter at both concentrations of His-Mor (400 and 800 ng). The in
vivo activity due to this mutation is much lower and does not seem to be because of the
binding effect of Mor to the promoter with this mutation. This mutation also introduced a
symmetrical substitution similar to mutation 9, but with a G/C combination as opposed to
the A/T combination that was introduced by mutation 9 at these positions. The closer-towild-type binding by His-Mor but significantly lower in vivo activity indicates that this
position probably contributes to the transactivation through interaction with RNA
polymerase. As noted earlier, this position lies in the region predicted to interact with one
of the α-CTD subunits of the RNAP, just like position -53A that was affected by
mutation 8 (Ma and Howe, 2004). This would explain why a mutation at this position
bound the protein but displayed a lower in vivo activity.
Mutation 11 (-32 G to T): This mutation conferred a red (wild-type) phenotype on
MacConkey plates, indicating a functionally active promoter. Its binding of His-Mor was
similar to that of wild-type promoter and its in vivo β-galactosidase activity of 1133 was
slightly higher than the wild-type promoter activity. Even though a symmetrical change
was made at this position with respect to -55A centered at -43.5, it did not increase the
binding of His-Mor. Thus, symmetry at this position may not contribute to Mor binding
and activation as both T and G are tolerated at this position, a finding understandable by
the observation that this position lies outside the Mor-binding region of Pm. The higher in
vivo activity of the promoter due to this mutation indicates the possible contribution of
this position to activation through interaction with RNAP which is increased by
substituting a T at this position.
Mutation 12 (-31 C to A): Colonies with this mutation exhibited a red (wild-type)
phenotype on MacConkey plates, indicating a functionally active promoter. The in vivo
β-galactosidase activity was 1139, slightly higher than wild-type promoter activity. The
gel shift showed a lower binding capacity of the promoter with this mutation to His-Mor;
60% to that of the wild-type promoter at both concentrations of His-Mor (400 and 800
ng). Even though a symmetrical change was made at this position with respect to -56T
centered at -43.5; it did not increase the binding of His-Mor. The lower binding of HisMor could be an experimental artifact as this position lies well outside the Mor-binding
region. Thus, symmetry at this position may be irrelevant to Mor binding. The higher in
vivo activity of the promoter with this mutation indicates the possible contribution of this
position to activation through interaction with RNAP, which is increased by substituting
an A at this position.
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Figure 19: Gel shift for mutations 13, 14 and 15.
Mutation 13 (-56 T to A and -31 C to T): This mutation led to a red (wild-type)
phenotype on MacConkey plates indicating a functionally active promoter. The in vivo
β-galactosidase activity was 1272, higher than the wild-type promoter activity observed
for -31 C to T alone. The gel retardation assay revealed similar to wild-type binding. The
closer-to-wild-type binding by His-Mor at both concentrations (400 and 800 ng) but
significantly higher in vivo promoter activity indicates that this position probably
contributes to transactivation through interaction with RNA polymerase. As noted earlier,
-56 lies in the region predicted to interact with one of the α-CTD subunits of RNAP, just
like position -53A and -54A that were affected by mutation 8 and mutation 10
respectively (Ma and Howe, 2004). The difference was that mutations 8 and 10
negatively affected the promoter activity while this mutation contributed positively to
promoter activity. This would explain why a mutation at this position bound His-Mor at
levels similar to the wild-type promoter but displayed a higher in vivo activity. Recall that
mutation -31 C to T alone gave a higher than wild-type promoter activity, it could
indicate a positive contribution of the single substitution in this mutation to binding with
the σ-CTD of the RNAP more effectively. Hence, if at all mutation -56 T to A contributes
to promoter activity, it would have a positive effect.
Mutation 14 (-57 G to T): Colonies with this mutation exhibited a red phenotype on
MacConkey plates indicating a functionally active promoter. Its binding to His-Mor was
similar to the wild-type promoter and its in vivo β-galactosidase activity was 902, very
close to the wild-type promoter activity. The similarity to wild-type binding can possibly
be explained by the observation that this position is well outside of the Mor-binding
region of Pm. The high in vivo activity of the promoter due to this mutation indicates a
possible contribution of this position to activation through its interaction with the RNAP
α-CTD subunit which is increased by substituting a T at this position; correlating with the
observation that this position lies in the region predicted to interact with one of the
α-CTD subunits of the RNAP (Ma and Howe, 2004). This would explain why a mutation
at this position bound the protein but displayed a high in vivo activity.
Mutation 15 (-57 G to T and -30 T to A): This mutation imparted a red phenotype with a
small white halo around the colonies, indicating somewhat lower promoter activity than
the wild-type, which correlated with its β-galactosidase activity of 647. The gel
retardation assay indicated that the promoter with this mutation had the capacity to bind
wild-type His-Mor to about 80% of the wild-type promoter at both concentrations of
His-Mor (400 and 800 ng) which partially explains its lower level of in vivo promoter
activity as measured in the β-galactosidase assay. The closer-to-wild-type binding by
His-Mor but significantly lower in vivo activity indicates that these positions contribute to
the activation of the promoter probably through its interaction with RNAP. Since
mutation 14 indicated the contribution from the individual substitution at -57 which gave
a wild-type activity, the effect of this double substitution is probably due to the
contribution of the -30 position. Changing the -30 T to A reduces the promoter activity,
probably indicating an important contribution of the -30T to RNAP interaction through
its σ-CTD subunit which binds to this region of the promoter.
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Figure 20: Gel shift for mutations 16 and 17.
Mutation 16 (-50 G to T and -41 G to T): This mutation imparted a red phenotype with a
small white halo around the colonies indicating a lower activity, which correlated with its
β-galactosidase activity of 421. The gel retardation assay with this mutant gave only
about 50% of the wild-type promoter binding to His-Mor at both concentrations of
His-Mor (400 and 800 ng). This weak binding to the promoter DNA would explain its
lower capacity to activate transcription from the promoter indicated by almost 60%
reduction in β-galactosidase activity. It indicates the importance of the nucleotides in
these positions for Mor binding. Even though the 6-bp segments that bind Mor were
made perfectly symmetrical to each other with an increased AT-rich sequence, binding
was negatively affected by the mutations, indicating that Mor binding to promoter DNA
in this region depends on specific bases and not the symmetry factor in binding the two
monomers of the Mor dimer. When compared to the effect of the single substitutions at
these positions, mutation 2 (-41 G to T) and mutation 26 (-50 G to T) both of which
reduced Mor binding to promoter DNA, the effect of this mutation seems to be the
combined effect of the two single mutations.
Mutation 17 (-50 G to T and -46 A to C): This double mutation imparted a red phenotype
with a small white halo around the colonies, indicating a slightly lower than wild-type
promoter activity which correlated with its β-galactosidase activity of 671. The in vitro
binding assay for this mutation was noteworthy in the fact that it repeatedly gave
significantly higher binding by His-Mor (almost three times the binding as compared to
the wild-type promoter). These mutations make the 6-bp segments perfectly symmetrical
to each other and it is these segments on either side of the spacer GCCG that binds the
two monomers of the Mor dimer. Mor binding to the promoter with this double mutation
imparts a high level of stability to the Mor-Pm complex indicated by the dramatically
higher binding in the gel shift assay. The hypothesis that increased Mor binding would
increase the promoter activity is refuted in this case. Since Mor recruits the RNAP to Pm,
the interactions between Mor and RNAP should be optimum for efficient recruitment of
RNAP to the promoter and also optimum for the release of σ70 during promoter
clearance and transcription elongation by the core RNAP. The higher binding of Mor
might interfere with the efficient release of σ70 during promoter clearance by lowering its
dissociation from the promoter. This might possibly explain why this mutation gave
higher binding with His-Mor but lower in vivo β-galactosidase activity.
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Figure 21: Gel shift for mutations 18 and 19.
Mutation 18 (-42 through -45 AAAA): This mutation led to red colonies with a small
white halo around them indicating lower promoter activity which correlated with its
β-galactosidase activity of 539. The gel retardation assay with this mutant promoter
showed significantly lower binding, only 40 % as compared to the wild-type promoter.
This weak binding to the promoter DNA would explain its reduced ability to activate
transcription from the promoter as indicated by its lower β-galactosidase activity. Since
side chains of Q68 and Y70 from the β-strand of Mor are proposed to interact with the
minor groove, these nucleotides in the minor groove may be important for Mor binding.
The A-rich sequence may change the dimensions of the minor groove altering the
stereochemistry of Mor interactions within the minor groove and the two major grooves
on either side.
Mutation 19 (-42 through -45 TAAT): This mutation resulted in red colonies with large
white halos, indicating lower promoter activity consistent with a β-galactosidase activity
of 344. In the gel retardation assay, this mutation led to significantly lower Mor binding
(∼40%) as compared to the wild-type. The weak binding of His-Mor to the promoter
DNA with this mutation would explain its reduced transcription activity. Since side
chains of Q68 and Y70 from the β-strand of Mor are proposed to interact with the minor
groove, these bases in the minor groove may be important for Mor binding. The A-rich
sequence may change the dimensions of the minor groove, altering the stereochemistry of
Mor interactions at the minor groove and in the two major grooves on either side.
The effect of the mutations 18 and 19, which make the minor groove spacer
AT-rich, indicates the preference for GC-rich sequences in the region. Thus it is not the
symmetry in this spacer that is important, but the presence of GC-rich sequences.
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Figure 22: Gel shift for mutations 20 and 21.
Mutation 20 (-42 through -45 GGCC): The mutant with these substitutions gave red
colonies with small white halos around them indicating slightly lower promoter activity
which correlated with its β-galactosidase activity of 618. The gel shift for this mutation
revealed a lower binding, of about 60% as compared to that of the wild-type at both the
concentrations of His-Mor used (400 and 800 ng). Thus the lower promoter activity due
to this mutation is possible because of the reduced binding of His-Mor. The difference in
the in vivo activity correlates with the difference in the binding of His-Mor at the
promoter with this mutation. The fact that this mutation maintains the GC-richness of the
minor groove spacer but significantly reduces binding by His-Mor indicates that it is not
the GC-richness alone, but the specific bases in the minor groove that are important. The
symmetry introduced by the wild-type may be important for Mor binding.
Mutation 21 (-42 through -45 GGGG): This mutation imparted a red (wild-type)
phenotype to the colonies on MacConkey plates indicating a functionally active
promoter. This was consistent with its binding, which was similar to the wild-type
promoter at both the concentrations of His-Mor used (400 and 800 ng) and it’s in vivo
β-galactosidase activity of 768. The lower β-galactosidase activity may indicate the
importance of these bases in the minor groove.
Recall that most of the base substitutions in the minor groove gave red colonies on
MacConkey plates; leading to the conclusion that the bases may not contribute
significantly to Mor binding and function. Comparing mutations 18 and 19 with
mutations 20 and 21 indicates that a somewhat GC-rich sequence may be preferred in the
minor groove spacer, though a mutation to AT-rich sequences does not very drastically
change the activity. Comparing mutation 20 and 21 in terms of their binding and
β-galactosidase activity, it is possible that the outer G’s might be more important than the
inner C’s of the GCCG spacer. Even though minor groove interactions appear to be
important for Mor binding, mutations of the bases in the minor groove do not affect Mor
binding as much mutations of the amino acids Q68 and Y70 (Kumaraswami, 2005).
Hence the amino acids probably interact with the minor groove spacer in a base
non-specific manner.
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Figure 23: Gel shift for mutations 22 and 23.
Mutation 22 (-57 G to T, -53 A to G and -31 C to T): The mutant with these base changes
mutation exhibited a red phenotype on MacConkey plates indicating it has a functionally
active promoter. This conclusion was further supported by its His-Mor binding to a level
similar to that of the wild-type promoter and an in vivo β-galactosidase activity of 1021,
which was close to the wild-type promoter activity. Even though the single mutations
individually at these positions recorded a high β-galactosidase activity, the effect is not
cumulative as indicated from the triple mutation. The similarity to wild-type binding can
possibly be explained by the fact that all three bases changed are outside of the
Mor-binding region of Pm. The high in vivo activity of the promoter due to this mutation
indicates the possible contribution of these positions to activation through interaction
with RNAP. Even though a promoter with these mutations binds His-Mor as effectively
as wild-type, these positions probably contribute to the transactivation through interaction
with RNA polymerase. As noted earlier, these positions lie in the region predicted to
interact with RNAP; -53 and -57 are in the region of the promoter predicted to interact
with one of the α-CTD subunits of the RNAP and -31 is in the region that interacts with
σ-CTD of the RNAP (Artsimovitch and Howe, 1996). This would explain why a
mutation at this position bound the protein as efficiently as wild-type promoter and
displayed a high in vivo activity.
Mutation 23 (-57 G to T and -53 A to G): This mutation conferred a red phenotype on
MacConkey plates indicating a functionally active promoter. This was further supported
by its binding assay which showed similarity to wild-type promoter. The in vivo
β-galactosidase activity was lower than the wild-type, only 642 relative to the wild-type
of 1000. The similar to wild-type binding can possibly be explained by the observation
that this position is outside of the Mor-binding region of Pm. Even though a promoter
with these mutations binds His-Mor as effectively as wild-type, the low in vivo activity of
the promoter due to this mutation indicates the possible contribution of these positions to
activation through interaction with RNAP. As noted earlier, these positions lie in the
region predicted to interact with RNAP; -53 and -57 are in the region of the promoter
predicted to interact with one of the α-CTD subunits of the RNAP (Ma and Howe, 2004).
This would explain why this mutation bound the protein as efficiently as the wild-type
promoter but displayed a lower in vivo activity.
Comparing mutations 22 and 23, the higher promoter activity of mutation 22 is probably
due to contribution from -31T which is in the region interacting with σ-CTD of the
RNAP than the other two (-57 G to T and -53 A to G).
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Figure 24: Gel shift for mutations 24 and 25.
Mutation 24 (-57 G to T and -31 C to T): This mutation imparted a red phenotype to the
colonies on MacConkey plates indicating a functionally active promoter. The in vivo
β-galactosidase activity was 1272, that was higher than the wild-type promoter activity as
observed for -31 C to T. The gel retardation assay revealed a similarity to wild-type
binding. The closer-to-wild-type binding by His-Mor at both the concentrations (400 and
800 ng) but significantly higher in vivo activity indicates that these positions probably
contribute to transactivation through interaction with RNA polymerase. These positions
lie in the region predicted to interact with RNAP subunits; position -57 is in the region of
the promoter predicted to interact with one of the α-CTD subunits of the RNAP and
position -31 is the region that is predicted to interact with σ-CTD of the RNAP
(Artsimovitch and Howe, 1996; Ma and Howe, 2004). This would explain why mutation
at these positions bound the protein as efficiently as wild-type promoter but displayed a
significantly higher in vivo activity. Comparing this with mutations 22 and 23 also
indicates the significant contribution of the -31T to promoter activity.
Mutation 25 (-53 A to G and -31 C to T): This mutation conferred a red phenotype to
colonies on MacConkey plates indicating a functionally active promoter which correlated
with the in vivo β-galactosidase activity of 816, which was close to the wild-type
promoter activity. The gel retardation assay revealed a similarity to wild-type binding.
The closer-to-wild-type binding by His-Mor at both the concentrations of His-Mor (400
and 800 ng) but slightly lower in vivo activity indicates that these positions probably
contribute to the transactivation through interaction with RNA polymerase. These
positions lie in the region predicted to interact with RNAP; -53 is in the region of the
promoter predicted to interact with one of the α-CTD subunits of the RNAP and the -31
is the region that interacts with σ-CTD of the RNAP (Artsimovitch and Howe, 1996; Ma
and Howe, 2004). This would explain why a mutation at this position bound the protein
as efficiently as wild-type promoter but displayed a slightly lower in vivo activity.
Comparing the in vivo promoter activity due to 1) mutation 25 and mutation 23 and 2)
mutation 25 with mutations 22 and 24, there is an indication of a significant contribution
of -31T to promoter activity than that of the other 3 positions.
Comparison of mutations 22 through 25 with mutation 14 (-57 G to T) indicates a
significant contribution by -57T though not as much as that by -31T. Comparing these
mutations with mutation 13 (-56 T to A and -31 C to T) also underlines the previous
observation. Comparing these with mutation 8 (-53 A to G), there is an indication that the
contribution by -53A is not as significant as those of the other two (-57T and -31T).
The observation that mutations 22 through 25 showed His-Mor binding similar to
wild-type promoter, but variations in their in vivo activity also alludes to the possibility
that mutations in these positions do not affect binding by Mor, but affect transcription
activation though interaction with the RNAP subunits.
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Figure 25: Gel shift for mutation 26.
Binding experiments with mutation 1 and mutation 17 on this gel were done to test the
reproducibility of the higher binding of His-Mor to the promoter with these mutations
and it was found to be so.
Mutation 26 (-50 G to T): This mutation conferred a red phenotype to the colonies on
MacConkey plates indicating a functionally active promoter. This was further supported
by its binding to His-Mor, which was just slightly lower to that of wild-type promoter and
its in vivo β-galactosidase activity of 863, that was also slightly lower than the wild-type
promoter activity. This mutation was designed to test the individual contribution by -50T
to mutation 17 (-50 G to T and -46 A to C), as mutation 17 gave twice the wild-type
binding by His-Mor in a gel shift in vitro binding assay. Base change -46C contributes
significantly to mutation 17 as seen from binding with mutation 1 (-46 A to C), but
contribution by the individual mutation -50 G to T is not significant. It might be that the
combination of -50T and -46C, which made the 6-bp segments on either side of the 4-bp
spacer (-42 through -45) is what makes it bind so efficiently to His-Mor by highly
stabilizing the Mor-Pm complex. Thus, the specific bases in the region of Mor binding are
important rather than the factor of symmetry as indicated by comparing mutations 16 and
17, which both made the segments perfectly symmetrical, though using different
substitutions.
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Figure 26: Gel shift for mutations 27, 28 and 29.
Mutation 27 (-48 A to T and -39 T to A): This mutation imparted white color to the
colonies on MacConkey plates indicating a severely defective phenotype similar to the
mutant with a deleted promoter. His-Mor failed to bind to the promoter DNA with this
mutation at levels even as high as 800 ng of protein, as seen from the gel shift data and
this explained its almost undetectable β-galactosidase activity of 0.5. It also indicates that
the bases are important for Mor recognition and binding and it is not just the symmetry
element because even thought we maintained the symmetry by swapping the nucleotides
between these positions in the already symmetrical wild-type promoter, it failed to bind
His-Mor.
Mutation 28 (-49 to -47 ATT and -40 to -38 AAT): This mutation also led to white
colonies on MacConkey plates indicating a severely defective phenotype similar to the
mutant with a deleted promoter. His-Mor failed to bind to the promoter with this
mutation at levels even as high as 800 ng of protein DNA, as seen from the gel shift data
and this explained its almost undetectable β-galactosidase activity of 0.8. It also indicates
that the bases are important for Mor recognition and binding and it is not just the
symmetry element because even thought we maintained the symmetry by swapping the
segments between these positions in the already symmetrical wild-type promoter, it failed
to bind His-Mor. Thus, the bases in these segments seem to be extremely critical for
binding with Mor as it does not tolerate any changes as shown by mutations 27, 28 and 3
(-48 A to C and -39 T to G).
Mutation 29 (-50 to -46 TATTC and -40 to -38 AAT): This mutation also led to white
colonies on MacConkey plates indicating a severely defective phenotype similar to the
mutant with a deleted promoter. His-Mor failed to bind to the promoter DNA with this
mutation at levels even as high as 800 ng of protein, as seen from the gel shift data and
this explained its almost undetectable β-galactosidase activity of 0.8. This mutation is a
combination of mutation 28 (-49 to -47 ATT and -40 to -38 AAT) and mutation 17 (-50
G to T and -46 A to C). Even though mutation 17 bound His-Mor extremely efficiently,
mutation 29 failed to do so indicating the significant contribution of the segments -49 to
-47 TAA and -40 to -38 TTA to mutation 17. It is not just -50T and -46C of mutation 17
that contributes to its high binding, but it is the effect of the mutations in combination
with the other bases in the 6-bp segment on either side of the 4-bp spacer.
The analysis of the mutations 3, 27, 28 and 29 together reveal the critical role played by
the specific bases in the Mor-binding region of Pm which lie as 2 imperfectly inverted
symmetrical elements on either side of the 4-bp spacer. They also indicate that it is the
presence of the specific bases in these positions that are important for Mor binding and
not just the factor of symmetry at these positions. As wild-type His-Mor failed to bind to
the promoter with these mutations, it could not activate transcription from that promoter
as it could not recruit RNA polymerase to the promoter. These specific bases seem to be
critical for the promoter binding and function of His-Mor.
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The length of the double-stranded oligonucleotides optimum for Mor binding
Different length oligonucleotides were designed starting with an 18-mer centered
at -43.5. Then two nucleotides were added corresponding to their positions in Pm, one on
either side of the 18-mer to obtain other oligonucleotides in the series: 20-mer, 22-mer,
24-mer, 26-mer, 28-mer and 30-mer. The list of the oligonucleotides used for this
experiment is given in Table 4. All the bottom strand oligonucleotides were radioactively
labeled with γ-P32 ATP, and gel shift reactions were set up with each double-stranded
pair, assaying with wild-type His-Mor binding at varying concentrations: 200 ng, 400 ng
and 800 ng. This experiment was done to identify the lowest length that would give an
optimum gel shift. The rationale behind designing the different length oligonucleotides
and using different levels of protein is as follows: there is a possibility that a shorter
length oligonucleotide which would fail to bind detectably to His-Mor at lower
concentrations, could bind His-Mor at higher protein concentrations, giving a detectable
shift in the assay. In contrast, it would help us determine the lowest concentration of
protein which would give an optimum detectable shift with longer oligonucleotides. This
can also be used as an indicator to determine the most critical bases that define Morpromoter DNA interactions and the minimum length of the oligonucleotide needed to
produce a detectable shift in the assay.
The pictures of the gels of this experiment are given in Figure 27. The following
observations were made from this experiment:
1. His-Mor failed to shift the 16-mer oligonucleotide duplex, probably because its
length is not sufficient for protein binding or that the double-stranded DNA
complexes and/or the His-Mor DNA complexes are unstable, hence undetectable
at experimental conditions.
2. All other length oligonucleotides bound His-Mor at all three protein levels used,
with minor differences.
3. At the levels of His-Mor protein used, increasing amounts of the protein gave
increasing intensities of bound probe, giving a gradually increasing gradient from
200 ng to 400 ng to 800 ng.
4. All the probes from at least a 22-mer and increasing to the 30-mer showed
similarity in their binding to the protein with no observable differences.
5. The capacity of binding of the 18-mer probe to the protein was lower than all
other size oligonucleotides at the three levels of protein used, indicating that even
though the binding of His-Mor to the 18-mer is detectable, this interaction is
probably more stable and/or more detectable in longer oligonucleotides.
In order to study the effect of mutations in the context of a longer stretch of Pm,
the 30-mer oligonucleotide was used for the study of mutations from -57 to -30 of Pm.
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Figure 27: Gel shifts with different size oligonucleotides.
A Gel shift with 18, 20 and 22-mer oligonucleotides
B Gel shift with 22, 24 and 26-mer oligonucleotides
C Gel shift with 26, 28 and 30-mer oligonucleotides
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Test whether Mor binding stabilizes the duplex oligonucleotide
For this experiment, the combined mutation -50T and -46C that gave the highest
binding to Mor were used. The hypothesis was that if this interaction between Mor and
DNA stabilizes the duplex, then we would get detectable and good shift in the assay with
shorter length oligonucleotides and/or at lower reaction times. For this a 16-mer, 18-mer
and 20-mer with the combined mutations -50T and -46C within the promoter, Pm were
used with wild-type His-Mor at 200 ng and 400 ng amounts and the reaction was set up at
three time points: 10, 20 and 30 min.
The pictures of the gels of this experiment are given in Figure 28. The following
observations were made from this experiment:
1. The 16-mer and 18-mer did not show detectable His-Mor binding at both the
protein levels and at all the time points.
2. The binding of His-Mor to the 20-mer at 10 min reaction time was barely
detectable.
3. At 400 ng of protein, the 20-mer was detectably bound after 20min reaction time
and the level of binding increased at the 30 min time point.
4. The same trend was observed with 200 ng of protein as with 400 ng though at
lower intensities.
5. The control 30-mer bound very efficiently to His-Mor even at 200 ng protein
level and as early as 10 min incubation time, and the amount of bound probe
increased with an increase in the reaction incubation time.

90

A

B

C

Figure 28: Gel shift to test Mor-oligo duplex stability.
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Chapter 3: Summarized results and discussion
The results of plate phenotyping, in vivo transactivation assays and in vitro
binding assays for all the specific mutations are presented in Table 7. For the
convenience of understanding, positions -30 to -57 of Pm promoter is divided into three
regions: the 4-bp minor groove spacer region, the 6-bp dyad-symmetry sequences and the
region flanking the Mor-binding sequences of Pm.
Results of the spacer region mutations (Figure 29)
About 60 mutants isolated with mutations in the spacer region gave red colonies,
indicating a wild-type phenotype. Functionally these can be classified as wild-type or at
least close-to-wild-type. Two GC-rich mutants were chosen for further analysis. GGGG
gave red colonies while CCGG had given an almost wild-type phenotype. In addition,
two more AT-rich mutants were isolated by targeted mutagenesis and analyzed further.
The AAAA mutation gave colonies which were red with a small white halo while the
TAAT mutation imparted almost a red-centered phenotype to the colonies. The βgalactosidase activities recorded for these mutants correlated with their phenotypes. The
red one had almost wild-type activity; the reds with a small white halo gave less than
wild-type activity and the red centered one had less than half of the wild-type activity.
None of the 60 isolated mutants imparted a severely defective phenotype or completely
abolished Mor binding. However, a clear gradation was seen with respect to Mor binding
and in vivo activity in the four mutations tested for them. This indicates that even though
the specificity of the bases in the 4-bp spacer region 5’ GCCG 3’ is not stringent, the
effect of mutagenesis of this region is detectable. Comparing this with the effect of
mutagenesis in the bases of the major groove of the Mor-binding site, it can be stated that
even though the minor grove bases do contribute to facilitate Mor binding, they are not as
important as the major groove bases. Thus, major groove interactions of Mor with DNA
play a major role at the promoter and the minor groove has a minor contribution.
Results of the mutations in the Mor-binding segments of the promoter (Figure 30)
The bases TAA in the positions -49, -48 and -47 and their symmetrical positions
occupied by bases TTA in positions -40, -39 and -38 are very interesting in the fact that
they do not tolerate any base changes. These positions are perfectly symmetrical in the
natural promoter; the bases and perhaps the symmetry in these positions seem to play a
major role in strengthening Mor-DNA interactions. This was supported by the
observation that any mutations in these positions exhibited a severe defect in Mor binding
and hence activation of Pm.
In this study, no mutagenesis was attempted in the positions -51 and -36 of Pm as
any mutations in these positions were previously found to be severely defective in
activation by Mor (Artsimovitch, 1996).
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Table 7: Summarized results of mutants: phenotypes, β-gal values and gel shift assays.
Mutation Mutation
number
1
-46 A to C
2

-41 G to T

3

-48 A to C and
-39 T to G
-37 A to C
-52 C to G

4
5
6
7
8

-52 C to A and
-35 C to T
-34 C to T
-53 A to G

9

-33 G to T

10

-54 A to C

11
12
13

-32 G to T
-31 C to A
-56 T to A and
-31 C to T
-57 G to T
-57 G to T and
-30 T to A
-50 G to T and
-41 G to T
-50 G to T and
-46 A to C
-42 through
-45 AAAA
-42 through
-45 TAAT

14
15
16
17
18
19
20
21
22

Phenotype
Red with small white
halo
Red with small white
halo
White
Red
Red with small white
halo
Red with small white
halo
Red
Red with small white
halo
Red with small white
halo
Red with larger white
halo than others
Red
Red
Red
Red
Red with small white
halo
Red with small white
halo
Red with small white
halo
Red with small white
halo
Red with large white
halo, almost red
centered
Red with small white
halo
Red

-42 through
-45 GGCC
-42 through
-45 GGGG
-57 G to T, -53 Red
A to G and -31
C to T
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β-gal
value
518

Gel shift
assay
+++++

377

++

0.4

-

951
639

+++++
++++

597

+++

809
630

++++
++++

654

++++

335

++++

1133
1139
1272

++++
++++
+++++

902
647

+++++
+++

421

+++

671

++++++++++

539

++

344

++

618

+++

768

+++++

1021

+++++

Table 7 (continued).
Mutation Mutation
Phenotype
number
23
-57 G to T and Red
-53 A to G
24
-57 G to T and Red
-31 C to T
25
-53 A to G and Red
-31 C to T
26
-50 G to T
Red
27
-48 A to T and White
-39 T to A
28
-49 to -47
White
ATT and
-40 to -38
AAT
29
-50 to -46
White
TATTC and
-40 to -38
AAT
Positive
No mutation
Red
Control
with
wild-type
Pm
Negative Deletion of Pm White
control
without
Pm

β-gal
value
642

Gel shift
assay
+++++

1488

+++++

816

+++++

863
0.5

+++
-

0.8

-

0.8

-

1000

+++++

5

-

β-gal Value standardized to the wild-type set as 1000.
+++++ is wild-type binding.
++++ is 75 to 90% of wild-type.
+++ is 50 to 75% of wild-type.
++ is 30 to 50% of wild-type.
++++++++++ is very high binding almost 200% of wild-type binding.
- is no detectable binding similar to the negative control.
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Red-small
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∼WT
β-GAL
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Figure 29: Summarized results of the spacer region mutations.
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Figure 30: Summarized results of the mutations in the Mor-binding segments of the
promoter.
Binding assay values are a percent of wild-type binding.
β-gal values are with respect to wild-type set to 1000.
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Base changes are also not tolerated at -41G, as any mutation at this position gave
weaker Mor binding and hence lower activation of Pm.
Base changes at the symmetrical positions -37A and -50G did not affect Mor
binding and promoter activity. These positions lie just within the imperfect dyad
symmetry, and they do not seem to play as significant a role in Mor-promoter interactions
as the other bases of the dyad symmetrical elements.
Positions -46A and -41G do contribute to Mor binding; mutation at -46 gave a
significantly higher Mor binding, while mutation at -41 negatively affected Mor binding.
These positions lie just outside the 4-bp spacer region and just within the dyad
symmetrical elements of the Mor monomer binding sites.
Mutations -50T and -46C together and -46C alone exhibited a remarkable binding
capacity to Mor, emphasizing the importance of these positions. This observation may be
useful while trying to crystallize Mor-DNA binary complexes to understand structural
aspects of their interactions. Surprisingly, this mutation gave a lower level of promoter
activity. Since Mor is proposed to recruit RNAP to the promoter through interactions
with the α-CTD and σ70 (Artsimovitch and Howe, 1996; Ma and Howe, 2004),
strengthening of Mor-DNA interactions may strengthen Mor-RNAP interactions; this
may negatively affect release of σ70 during promoter clearance. Thus, the interactions
between Mor and DNA should be optimum not only to recruit RNAP to the promoter but
also for the subsequent release of RNAP subunits to facilitate transcription. This fact
leads to the hypothesis that Mor binds the promoter to direct and recruit RNAP to the
promoter and subsequently has to be released from the DNA as transcription begins.
A majority of the activators influence the recruitment of RNAP in the
transcription initiation. The activators either increase RNAP binding to the promoter or,
when it is already bound, influence isomerization from the closed to open promoter
complex. For example, CAP increases the initial binding of RNAP at the lac promoter,
and λcI protein positively influences the rate of isomerization at the λPRM promoter. A
few activators have also been shown to act at a post-recruitment step of transcription
initiation, as observed in the case of Arc, which enhances promoter clearance from the
Pant promoter of bacteriophage P22 during late lytic growth. A given activator can also
influence different steps of transcription initiation in different promoters. Most of the
CAP-dependent promoters are regulated at the RNAP recruitment step; however, at the
malT promoter, CAP enhances promoter clearance. Using the CAP and mutant lac
promoter, it has been demonstrated that regulatory proteins could act as activators or
repressors in different steps of the transcription initiation pathway, depending on the
energetic differences of the intermediate complexes. In the vast repertoire of transcription
activators, there are few that act at multiple steps of transcription initiation at a single
promoter. The most well known example is CAP-mediated activation of the initial
binding of RNAP and subsequent isomerization at the gal P1 promoter. Recruitment of
RNAP and subsequent promoter clearance at the λPR promoter are enhanced by DnaA.
Fis has been reported to sequentially stimulate transcription initiation steps at the tyrT
promoter by facilitating initial binding of RNAP, unwinding of DNA at the transcription
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start point, and subsequent promoter clearance. At the PRE promoter of the λphage, cII
protein enhances both the formation and stability of the RNAP-promoter open complex.
Transactivator C protein of phage Mu acting at the late promoter Pmom has also been
indicated to belong to a small group of activators acting at multiple steps of promoterpolymerase interactions in a single promoter (Chakraborty and Nagaraja, 2006). Thus,
based on the above observation, Mor could belong to the group of transcriptional
activators affecting multiple steps of promoter-polymerase interactions at promoter Pm
including its effect on promoter clearance.
Results of the mutations in the region beyond Mor-binding segments of the
promoter (Figures 31, 32 and 33)
Positions -52 and -35 of Pm do contribute to Mor binding as well as promoter
activity, indicating that these positions have a contribution to Mor binding as they lie just
outside the Mor-binding sites on either side.
Positions -57 through -53 which lie upstream of the Mor-binding site and
positions -34 through -30 which are downstream of the Mor-binding site do not have a
dramatic effect on Mor binding, but they do affect promoter activity. The observation that
mutations in this region affect promoter activity may reflect a contribution of these
regions in atypical interaction with the subunits of RNAP.
The region -29 to -33 was previously predicted to overlap the region that
undergoes a structural change in the form of a distortion which confers flexibility to the
DNA and is probably necessary for the precise alignment of Mor and RNAP. The fact
that this region may occur in the Mor-RNAP interface also raises the possibility of a
contribution of this region to promoter activity by affecting either Mor-RNAP
interactions or RNAP-DNA interactions (Artsimovitch and Howe, 1996).
Bases -57 to -54 lie in the region that was previously predicted to be the UP-like
element on the promoter distal side of the Mor-binding site (Ma and Howe, 2004). The
results of mutagenesis of this region is consistent with the prediction that one of the αCTD subunits of RNAP interacts with this region, and the effect of mutations in this
region to promoter activity is probably due to this interaction, which is either
strengthened or weakened depending on the type of base changes in these positions (Ma,
2004). The observation that positions -53 and -54 contribute more than positions -56 and
-57 is also consistent with the previous observations (Ma, 2004).
Thus, region -57 to -30 of Pm is important for activity of the promoter either
directly or indirectly (Figure 34). The direct effect of the spacer region and the imperfect
dyad symmetrical element and the bases just flanking them is revealed from Mor-binding
experiments. The indirect contribution of the positions beyond the Mor-binding site on
either side can be hypothesized from activity assays and previous observations and
predictions for their involvement in interactions with the RNAP subunits or their
predicted effects on conformational changes in this region.
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Figure 31: Summarized results of mutations at positions just flanking the Mor-binding
segments.
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Figure 32: Summarized results of mutations at positions beyond the Mor-binding
segments.
Binding assay values are a percent of wild-type binding.
β-gal values are with respect to wild-type set to 1000.
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Figure 33: Summarized results of additional mutations.
Binding assay values are a percent of wild-type binding.
β-gal values are with respect to wild-type set to 1000.
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major groove bases.
2. Extremely critical for Mor binding in the major groove, no mutations are tolerated.
3. Critical major groove bases for interaction with Mor; coincides with the dyad
symmetry Mor-binding segments.
4. Some contribution to Mor binding, and some to interaction with RNAP
a) probably with σ subunit of RNAP
b) probably with α-CTD of RNAP
5. Contributes to interaction with RNAP subunits
a) probably with σ subunit of RNAP
b) probably with α-CTD of RNAP

Figure 34: General conclusions from mutagenesis of the middle promoter.
The regions are color coded with the font colors corresponding to the colors of the
segments marked. Bases from -30 to -57 upstream of the transcription start site are given
with their numbers given above the bases.
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Major findings from the current work
The findings describe the impact of this work on our understanding of Mor-Pm
interactions.
1. Demonstrated some contribution of the minor groove spacer region to Mor
binding.
2. Identified positions extremely critical for Mor interactions at the promoter.
3. Identified positions that have a modest contribution to interaction with activator
Mor.
4. Predicted positions of the promoter that affect transactivation. This could be
through direct interaction with RNAP subunits or through indirect conformational
changes.
5. Higher affinity binding of Mor to promoter correlates with reduced promoter
activity probably due to ineffective promoter clearance. This indicates a dual role
for activator Mor at the promoter: recruitment of RNAP to the promoter and
release of core RNAP during promoter clearance and transcription initiation.
Future directions
The following possible experiments are proposed to dissect the protein-protein
and protein-DNA interactions between Mor, Pm, and the different subunits of RNA
polymerase and to define their respective roles in middle promoter regulation.
1. To identify amino acid positions of Mor that interact with regions of promoter.
2. To investigate and further understand interactions between RNAP subunit and
promoter positions.
3. To find out whether positions beyond Mor-binding region directly contribute to
RNAP subunit interactions or indirectly contribute by affecting conformational
changes at Mor-DNA-RNAP interfaces.
4. In most cases, protein-protein contacts between the activator and different
subunits of RNAP, mainly the α-CTD, are the basis for transcription activation
(Dove et al, 2000). The role of protein-protein contacts between Mor-α-CTD and
Mor-σ-CTD in the efficient recruitment of RNAP to Pm and in Mor-dependent Pm
activation is well established (Artsimovitch et al, 1996). A structure-guided
targeting of the side chains of specific residues of Mor can be carried out to
identify the RNAP contact sites in Mor. As indicated by structural homology, Mor
binds to the major groove using primarily the residues from the tip of the
recognition helix, α5. When Mor binds to DNA in an “ends-on mode”, two
regions of the protein would be in close proximity to the C-terminal domains of α
and σ of RNAP. The amino acid side chains on the external face of preceding
helix α4. In ends-on mode of base recognition, the body of the preceding helix is
left out of the major groove and solvent-exposed. Contacts involving minimal
protein-protein interface is not uncommon in activator-RNAP contacts. Another
characteristic feature of ends-on DNA-binding is that most of the C-terminal part
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of recognition helix sticks out of the major groove and away from DNA. The
basic-rich C-terminal tail of Mor presents an ideally located surface for
electrostatic interactions between Mor and different subunits of RNAP. The
frequency of the defective phenotypes in the mutant library might not be as
drastic as it is seen in case of residues that are predicted to be involved in basespecific interactions. So isolation of phenotypically selected mutations and a
detailed functional characterization of the mutant proteins would be necessary to
define their role in protein-protein contacts, thereby transcription activation.
5. To test the prediction between inverse correlation between affinity of Mor binding
and effective promoter clearance.
6. UV-photo cross-linking and mass spectrometry: Identification of the specific
contacts between Mor with middle promoter is essential to understand the basis
for the promoter recognition. Interaction between DNA-binding proteins and their
binding site generally involves a combination of base-specific interactions and
non-specific interactions with phosphate backbone and sugar. The sequencespecific DNA-binding proteins, such as Mor, discriminate their binding site from
a vast majority of random sequences by specific interactions, whereas the nonspecific interactions provide the stability to the binary complex. UV-photo crosslinking in tandem with mass spectrometry have emerged as a useful tool in the
identification of specific interactions. The technique generally involves UV crosslinking of DNA with modified bases to the side chains of amino acids it interacts
with. UV irradiation of derivatized nucleobases such as 5’-iodouracil generates
highly reactive intermediates that form zero-length cross links to the amino acid
side chains in the vicinity. This covalently cross-linked heteroconjugates can be
subjected to protease digestion and/or nuclease digestion to reduce the size of the
peptide or nucleotide fragments. The purified fragments can be analyzed on a
Matrix-Assisted Laser Desorption/Ionisation Time-Of-Flight Mass Spectrometry
(MALDI-TOF MS).
7. Findings can be used to optimize the positions of the promoter with respect to
those that affect Mor-binding and α-CTD-binding for crystallographic studies on
(a) Mor-DNA binary complex
(b) Mor-DNA-α-CTD ternary complex.
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Appendix: Determining the effect of N- and C-terminal
deletions of Mor
In the Mor/C family of proteins the least conserved regions are the N-terminal and
C-terminal portions of as shown in Figure 35. These are also the portions of Mor that are
not visible in the crystal structure. It is important to note, however, that these sequences
are not random; they simply show a smaller number of matches than the central region.
Their potential importance to Mor function is underscored by the fact that deletion of the
26 N-terminal or 9 C-terminal amino acids, not seen in the structure, render Mor nonfunctional (Kumaraswami et al, 2004). Thus, the N- and C-terminal regions of Mor may
be important for its structure and stability, binding to DNA or transcription activation
through interactions with RNA polymerase. In order to determine the functional
relevance of these terminal regions, serial deletions were made from both ends. For the
N-terminus, 5, 10, 15, 20 and 25 amino acids were deleted and at the C-terminus, 3, 6, 9,
12 and 15 amino acids were deleted.
Primers with the above deletions were used in PCR reactions to create the deleted
mor genes. Table 8 shows the sequences of the oligonucleotides that were used in this
study. The N-terminal deletion primers retained the codon for the initiating methionine
following the His-tag and the C-terminal deletion primers retained the stop codon. The
deletion was made in two steps as shown in Figure 36: For the N-terminus, the top strand
deletion primer was used with the bottom strand wild-type primer ZAO 3 in PCR
amplification reaction to create PCR product 1. At the same time, the bottom strand
primer with overlap to the N-terminal deletion primers was used with MUT 13 in a
separate PCR reaction to create PCR product 2. The resulting PCR products 1 and 2 with
overlapping ends were used as templates in another PCR reaction, and amplification was
achieved using top and bottom strand wild-type primers, MUT 13 and ZAO 3,
respectively. A similar strategy was used to make the C-terminal deletions with the
difference that the deletion bottom-strand primers were used with MUT 13 for
amplification, while the top strand overlap primer was used with ZAO 3. The PCR
reaction combining the first two PCR products was similar to that for the N-terminal
deletions. The template for the first and second PCR amplification reactions was the
wild-type pIA69 which carries the his-mor gene under the influence of an IPTG-inducible
PlacUV5 promoter. After purification of the final PCR products with a Qiaquick PCR
purification kit, they were sequentially digested with NdeI and BamHI at 37°C for 3
hours each. The digested products were again purified with a Qiaquick PCR purification
kit and ligation reactions were set up with the similarly digested vector pIA69, and
incubated at 16°C overnight. The ligation mixture was transformed into MH13435
carrying the Pm-lacZ fusion plasmid pIA14. The resulting transformants were selected on
MacConkey lactose indicator plates with 50 µM IPTG, chloramphenicol (25 μg/ml) and
ampicillin (40 μg/ml); the promoter plasmid, pIA14 confers ampicillin resistance and the
protein plasmid, pIA69 confers chloramphenicol resistance. Candidate clones were
purified and sequenced to identify the deletions. The phenotypes resulting from the Nand C-terminal deletions are listed in Table 9.
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Figure 35: Amino acid and secondary structure alignment for Mor and C proteins of
bacteriophage Mu.
α-helix is shown as an oval and β-strand as an arrow. Identical amino acids are shown in
black boxes; chemically similar residues are shaded in gray. Dots indicate 10 amino acid
intervals in Mor.
Modified with permission from American Society for Biochemistry and Molecular
biology. Kumaraswami M, Howe MM, Park HW. Crystal structure of the Mor protein of
bacteriophage Mu, a member of the Mor/C family of transcription activators. J Biol
Chem. 2004, 279(16): 16581-90.
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Table 8: Oligonucleotides used for N- and C-terminal deletions of His-Mor.
Primer

Sequence (from 5’ to 3’ end)

Comments

KRI 1

GATGACGATAAGATG Δ
GGTGATCTGCAGGATGACAC
GATGACGATAAGATG Δ
GACACCATCCTGGCACAT
GATGACGATAAGATG Δ
CATCTTGACAATCC
GATGACGATAAGATG Δ
GCCGAGGACACGTCACGCTTT
GATGACGATAAGATG Δ
CGCTTTCCGGCACTGCTGGCGGAG
CATCTTATCGTCATCGTCGAG

For deletion of 5 amino acids
from the N-terminus of Mor.
For deletion of 10 amino acids
from the N-terminus of Mor.
For deletion of 15 amino acids
from the N-terminus of Mor.
For deletion of 20 amino acids
from the N-terminus of Mor.
For deletion of 25 amino acids
from the N-terminus of Mor.
Bottom strand primer with
overlapping region with
N-terminal deletion primers.
For deletion of 3 amino acids
from the C-terminus of Mor.
For deletion of 6 amino acids
from the C-terminus of Mor.
For deletion of 9 amino acids
from the C-terminus of Mor.
For deletion of 12 amino acids
from the C-terminus of Mor.
For deletion of 15 amino acids
from the C-terminus of Mor.
Top strand primer with
overlapping region with
N-terminal deletion primers.
Wild-type top strand primer
beyond 5’ end of mor gene.
Wild-type bottom strand
primer beyond 3’ end of mor
gene.

KRI 2
KRI 3
KRI 4
KRI 20
KRI 5
KRI 6

KRI 8

CGGCTTTACTGTTTA Δ
GGGCTGGTACTGGCGGTA
CGGCTTTACTGTTTA Δ
CTGGCGGTATTTCA
CGGCTTTACTGTTTA Δ
TTTCAGCCGTCG
CGGCTTTACTGTTTA Δ
TCGCATGCGGCGAAT
CGGCTTTACTGTTTA Δ
GCGAATGGCTTTGTACACCGTA
TAAACAGTAAAGCCGGTTAATCC

MUT 13

CCAGGCTTTACACTTTATGC

ZAO 3

ACCTGAAGTCAGCCCCATAC

KRI 7
KRI 21
KRI 22
KRI 23

The oligonucleotide sequences are written from the 5’ to the 3’end.
Δ indicates the position of the deletion from the mor gene.
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MUT 13

Primer with N-terminal deletion

I
Primer with overlap

ZAO 3

PCR product 2
PCR product 1

II

III
PCR product 3 with the deletion

Figure 36: Schematic diagram of the strategy used for deletion of amino acids from the
N-terminus of Mor.
The shaded block represents the part of pIA69 with the mor gene. The Δ shows the region
of deletion. Layer I shows the position of the primers used for first set of amplification
reactions. Layer II shows the products of the first two amplifications, their regions of
overlap, and the region deleted. Layer III shows the final PCR product containing the
deletion in the mor gene.
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Table 9: Resulting phenotypes of the N- and C-terminal deletion proteins.
N-terminal
deletions of Mor
Δ 5 amino acids

Phenotype of the
colony with the
deletion
Red

Δ 10 amino acids

Red

Δ 15 amino acids

White

Δ 20 amino acids

White

Δ 25 amino acids

White

C-terminal
deletions of Mor
Δ 3 amino acids

Phenotype of the
colony with the
deletion
Red

Δ 6 amino acids

Red

Δ 9 amino acids

White

Δ 12 amino acids

White

Δ 15 amino acids

White

Δ indicates deletion.
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Protein over-expression and small-scale protein purification for gel shift assay
were performed as described in material and methods. Labeled probe was prepared using
a γ-P32 labeled primer MLK 7 and unlabeled IRI 21 in a PCR reaction using pIA14,
containing Pm sequences from -61 to +10 as template. The labeled probe was purified
with a Qiaquick PCR purification kit. A 20 μl reaction volume containing about 50
counts per second of radioactive probe, 50 ng of calf-thymus DNA, and different
concentrations of the protein in binding buffer (20 mM Tris-HCl pH 7.9, 50 mM NaCl,
5% glycerol and 1 mM DTT) was incubated at room temperature for 20 minutes. The
reaction mixture was resolved on a 10% non-denaturing, native acrylamide gel containing
0.5 X TBE and run in 0.5 X TBE buffer at 260 V for 3 hours at 4°C. Initial exposure of
the gels to X-OMAT BioMax-MR films was done without drying.
DNA-binding assays with the C-terminal deleted His-Mor proteins showed that
proteins with Δ3C and Δ6C at the C-terminus retained DNA-binding ability correlating
with their red colony phenotype. DNA-binding assay for Mor proteins carrying Cterminal deletions is shown in Figure 37. Both Δ3C and Δ6C proteins bound the probe
less than the wild-type and the Δ3C protein bound the probe less than Δ6C protein at both
concentrations of protein used. For the two deletions and the wild-type, 800 ng of protein
bound the probe more than 400 ng of the probe as indicated by the intensity of the shift.
Δ9C, Δ12C and Δ15C did not bind the DNA probe at concentrations even as high as 800
ng of His-Mor. Thus, the contribution by the last 6 amino acids of Mor is less critical
than the others at the C-terminus as their deletion gave us functional protein in terms of
binding to DNA as well as transactivation as indicated by red colony phenotype. It would
be useful to investigate the importance of the amino acids at the C-terminus in terms of
their contribution to Mor structure and function.
An experiment was done to observe the shift by lower concentration of the
protein. The gel shift for this experiment is shown in Figure 38. As observed previously,
Δ6 C-terminus of His-Mor gave functional protein with respect to DNA-binding and
hence activation determined by the red color of the colony. Δ6C bound the probe less
than the wild-type. For Δ6C and the wild-type, the amount of probe bound to the protein
gradually increases as the amount of protein increases in the reaction as indicated by the
intensity of the shift. Δ6C bound the probe even at concentration as low as 200 ng of
protein, but Δ9C did not bind the DNA probe at concentrations even as high as 800 ng of
His-Mor.
Similar to the C-terminus, DNA-binding experiments were done for proteins
deleted from the N-terminus. DNA-binding assays with the deleted His-Mor proteins
showed that proteins with Δ5N and Δ10N at the N-terminus retained DNA-binding
ability consistent with their red colony phenotype. Both Δ5N and Δ10N proteins bound
the probe less than the wild-type and Δ10N protein bound the probe more than Δ5N at
both concentrations of protein used. For the two deletions and the wild-type, 800 ng of
protein bound the probe more than 400 ng of the probe as indicated by the intensity of the
shift. Δ15N, Δ20N and Δ25N did not bind the DNA probe at concentrations even as high
as 800 ng of His-Mor. Thus, the contribution by the first 10 amino acids of Mor is less
critical than the others at the N-terminus as their deletion gave us functional protein in
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Figure 37: Gel shift for Mor proteins carrying C-terminal deletions.

Figure 38: Gel shift for Δ6C and Δ9C Mor proteins.
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terms of binding to DNA as well as transactivation as indicated by red colony phenotype.
DNA-binding assay for Mor proteins carrying N-terminal deletions is shown in Figure
39. It would be useful to investigate the importance of the amino acids at the N-terminus
in terms of their contribution to Mor structure and function.
An experiment was done to observe the shift by lower concentration of the
protein. The gel shift for this experiment is shown in Figure 40. As observed previously,
Δ10N of His-Mor gave functional protein with respect to DNA-binding and hence
activation determined by the red color of the colony. Δ10N bound the probe less than the
wild-type. For Δ10N and the wild-type, the amount of probe bound to the protein
gradually increases as the amount of protein increases in the reaction as indicated by the
intensity of the shift. Δ10N bound the probe even at concentration as low as 200 ng of
protein, but Δ15N did not bind the DNA probe at concentrations even as high as 800 ng
of His-Mor.
It was observed reproducibly in the N-terminal deletion and C-terminal deletion
gels that a band appeared as the number of amino acid deleted increased. So, an
experiment was done to test if any other proteins from the cell supernatant bind the DNA
probe and result in a shift in the probe. A constant amount of wild-type His-Mor (400 ng)
was used with increasing amount of cell supernatant. The supernatents were from a strain
that did not have his-mor gene in its plasmid. Since there are no additional bands that
appear to be shifted with concentrations as high as 6400 ng of the supernatant used, it
could be concluded that no other protein from the cell supernatant fraction other than HisMor bound the probe as seen in Figure 41.
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Figure 39: Gel shift for Mor proteins carrying N-terminal deletions.

Figure 40: Gel shift for Δ10N and Δ15N Mor proteins.
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Figure 41: Gel shift with increasing amounts of supernatant.
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